Clinical Decision Rules (2024)

by Stacey Chamberlain

Definitions and Overview

Clinical Decision Rules (CDRs), also known as Decision “Instruments” or “Aids,” are evidence-based tools to assist the practitioner in decision-making for common complaints. In the Emergency Department (ED) setting, these decision aids are often used to help identify patients who might be at higher risk for serious conditions such as pulmonary embolism (PE) or intracranial hemorrhage (ICH), or they are used to prevent overuse of unnecessary testing, which is how many of the orthopedic rules are applied. 

CDRs, despite being called “Rules,” are not meant to replace critical thinking from experienced practitioners. In fact, many CDRs have been directly compared against clinician gestalt or clinical practice, and they are not always better [1,2]. Additionally, some rules incorporate clinician gestalt, whereas the rule cannot even be applied unless the pre-test probability (based on the physician’s judgment of the likelihood of the disease) is below a pre-determined threshold [3]. Also, for a CDR to be useful to a practitioner, it must be practical. If a CDR is developed that has too many complicated variables, it is unlikely to be applied in a busy clinical environment  [4].

Another caveat to the application of CDRs is that they must be applied appropriately.  CDRs evolve through a process of derivation to validation to impact analysis of the tool. After the tool is derived (level 4 evidence), the tool is validated in a limited patient setting (level 3 evidence), then a broader validation setting (level 2 evidence), and finally, the impact of the tool is assessed (level 1 evidence) [5]. These levels are important to caution the novice learner against applying every CDR which has been derived and published automatically into their clinical practice. The tool must be validated in a patient population with similar characteristics to the practitioner’s patient population. For example, the tool may not perform the same (have the same sensitivity and specificity) if the prevalence of disease is different between the study and actual patient populations. Also, the practitioner must be familiar with a particular tool’s inclusion and exclusion criteria. If not, the tool could be misused. For example, if the tool was derived and validated for a patient population over the age of 18, it should not be inappropriately applied in a pediatric setting.

The practitioner must also understand the purpose of the CDR and whether it is a one-way or two-way rule. As noted by Green, for example, the Ottawa Ankle Rules are intended to be a two-way rule; if the patient meets the criteria, you do an X-ray; if they don’t meet the criteria, you do not do an X-ray [6]. There are two paths you can take after you apply your CDR. Alternatively, the pulmonary embolism rule-out criteria (PERC) demonstrate a one-way rule. This tool was developed to identify a subset of patients at very low risk for PE so that no further testing is needed. If the patient is “PERC positive,” this should not imply that further testing for PE, such as a D-dimer or CT angiogram of the chest, should be done. Whether or not additional testing should be done remains up to the practitioner and depends on many variables, including whether an alternate diagnosis is much more likely. PERC was designed to help “rule out” the diagnosis of PE, not “rule in.” This rule only guides you down one path: potentially, to do no testing; it makes no judgment as to what you should do if the patient is “PERC positive.”

In addition to CDRs, many risk stratification tools or scales have been used for serious conditions such as pulmonary embolism (PE) and acute coronary syndrome (ACS). Others have more recently been developed for use in the ED setting for common conditions such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and transient ischemic attack (TIA) to identify patients at higher risk for acute severe complications [7]. From a practical perspective, the ED physician will often use these risk stratification devices to help determine which patients require admission. However, these tools are less prescriptive in that they are not rules that suggest what a practitioner should or should not do, but rather, they help the physician more objectively look at the risk for an individual patient. Then the practitioner must decide what level of risk they are comfortable with in regards to inpatient or outpatient management, which may greatly depend on the resources available in those environments. Most of the risk stratification tools encompass multiple variables with more complicated scoring systems; as they are not easily memorized, most of these would typically be used by ED physicians with real-time access to a computer or smartphone with appropriate apps.

Given the many pitfalls noted above of CDRs, the goals of using evidence-based medicine to reduce practice variability, maximize cost-effective use of resources, and help identify and diagnose high-risk conditions are important.  It is equally important that the ED physician critically appraise these tools and selectively apply them in appropriate ways [8]. The remainder of this chapter will use case scenarios to review the most commonly used CDRs in the ED setting.

The useful FOAM reference MDCalc.com provides a summary of the most common tools that are being used with easy-to-use online calculators and additional information on inclusion and exclusion criteria, evidence basis for the tools, as well as pearls and pitfalls for each tool.

Orthopedic CDRs

Ottawa Knee, Ankle and Foot Rules

Case 1

A 28-year-old man presents to the ED with left ankle pain after twisting his ankle while playing basketball.  He is able to bear weight and notes pain and swelling to the lateral aspect of the ankle (he points to just below the lateral malleolus).  He denies weakness, numbness, or tingling and has no other injuries.  On exam, he is neurovascularly intact.  Edema and tenderness are noted slightly anterior and inferior to the lateral malleolus.  There is no point tenderness to the distal posterior malleoli bilaterally.

Should you obtain an X-ray to check for a fracture?

Ankle sprain - Image was created by ideogram 2.0

Ottawa Ankle Rule

Pain in the malleolar zone and any one of the following:

  • Bone tenderness along the distal 6 cm of the posterior edge or tip of the tibia (medial malleolus), OR
  • Bone tenderness along the distal 6 cm of the posterior edge or tip of the fibula (lateral malleolus), OR
  • An inability to bear weight immediately and in the emergency department for four steps.
Tenderness over posterior tibial malleolus (image generated by using virtual human body and Canva)
Tenderness on posterior or tip of the lateral malleolus (image generated by using virtual human body app and Canva).

Ottawa Foot Rule

Pain in the midfoot zone and any one of the following:

  • Bone tenderness at the base of the fifth metatarsal, OR
  • Bone tenderness at the navicular bone, OR
  • An inability to bear weight immediately and in the emergency department for four steps.
Tenderness at the base of the fifth metatarsal OR navicular bone (image generated by using virtual human body app and Canva).

Ottawa Knee Rule

Knee injury with any of the following:

  • Age 55 years or older
  • Tenderness at the head of the fibula
  • Isolated tenderness of the patella
  • Inability to flex to 90°
  • Inability to bear weight both immediately and in the emergency department (4 steps)
Tenderness at the patellar OR head of the fibula (image generated by using virtual human body app and Canva).

The Ottawa knee, ankle, and foot rules are some of the longest-standing and most widely accepted CDRs. These rules help practitioners identify patients with an extremely low risk of fracture such that X-rays do not need to be done, thus limiting the risks and costs of unnecessary testing. The sensitivity of these rules has been found to be 98.5-100% [9-11]. In impact study of the Ottawa knee rule, application of the rule decreased the use of knee radiography without patient dissatisfaction or missed fractures and was associated with reduced waiting times and costs. These rules have also been validated in pediatric populations with similar sensitivities (98.5-100%) [12-14].

Case 1 Discussion

Base on the Ottawa ankle rule, an X-ray is unnecessary. The patient can be treated supportively for an ankle sprain. When it comes to treating an ankle sprain, supportive care is typically the most effective approach. This involves several key strategies aimed at reducing pain and promoting healing. First and foremost, it’s important to follow the R.I.C.E. method:  

  1. Rest: Avoid putting weight on the injured ankle to prevent further damage. This might mean using crutches or a brace, especially in the initial days after the injury.
  2. Ice: Applying ice packs to the ankle for 15-20 minutes every couple of hours can help reduce swelling and numb the pain. It’s crucial to wrap the ice pack in a cloth to protect the skin.
  3. Compression: Using an elastic bandage or compression wrap around the ankle can help minimize swelling and provide support. It’s essential not to wrap it too tightly, as this could impede circulation.
  4. Elevation: Keeping the ankle raised above the level of the heart can also help reduce swelling and improve blood flow to the area, speeding up the healing process.

In addition to the R.I.C.E. method, over-the-counter pain relievers like ibuprofen or acetaminophen can be used to manage pain and inflammation. Gradually reintroducing movement and gentle stretching exercises can aid in restoring strength and flexibility, but this should be done cautiously and ideally under the guidance of a healthcare professional. Physical therapy may also be beneficial in some cases, especially if the sprain was severe or if there are concerns about stability in the ankle after healing. A physical therapist can provide tailored exercises and techniques to regain strength and prevent future injuries. Overall, the goal of supportive treatment for an ankle sprain is to promote recovery while alleviating pain, allowing the patient to return to their normal activities as safely and quickly as possible.

Trauma CDRs

Canadian Cervical Spine and NEXUS Rules

Case 2

A 57-year-old man fell from a height of 12 feet while on a ladder. He did not pass out; he reports losing his footing. He fell onto a grassy area, hitting his head, and complains of neck pain. He did not lose consciousness and denies headache, blurry vision, vomiting, weakness, numbness or tingling in any extremities. He denies other injuries. He was able to get up and ambulate after the fall and came in by private vehicle. He has not had previous spine surgery and does not have known vertebral disease. On exam, he is neurologically intact with a GCS of 15, does not appear intoxicated, and has moderate midline cervical spine tenderness.

Should you obtain imaging to rule out a cervical spine fracture?

a-photo-of-a-57-year-old-male-who-fell-from-a-ladder (image generated by ideogram2.0)

Canadian C-spine Rule

  • Age ≥ 65
  • Extremity paresthesias
  • Dangerous mechanism (fall from ≥ 3ft / 5 stairs, axial load injury, high-speed MVC/rollover/ejection, bicycle collision, motorized recreational vehicle)

NEXUS Criteria for C-spine Imaging

  • Focal neurologic deficit
  • Midline spinal tenderness
  • Altered level of consciousness
  • Intoxication
  • Distracting injury

Case 2 Discussion

Applying either criteria to this case would require C-spine imaging, as by CCR, the patient would meet the criteria for dangerous mechanism, and by NEXUS, the patient has midline tenderness to palpation.

Canadian CT Head Rule and NEXUS Head CT Instrument

Case 3

A 36-year-old woman slipped on ice and fell and hit her head. She reports loss of consciousness for a minute after the event, witnessed by a bystander. She denies having headaches. She denies weakness, numbness, or tingling in her extremities and no changes in vision or speech. She has not vomited. She remembers the event except for the transient loss of consciousness. She doesn’t use any blood thinners or have any known coagulopathy. On physical exam, she has a GCS of 15, no palpable skull fracture or scalp hematoma, no signs of a basilar skull fracture, normal mentation, and no neurologic deficits.

Should you obtain a CT head for this patient to rule out a clinically significant brain injury?

a-photo2-of-a-36-year-old-woman-who-slipped-on-ice-(image generated by ideogram2.0)

Canadian CT Head Rule

High Risk Criteria (rules out need for neurosurgical intervention)

  • GCS < 15 at two hours post-injury
  • Suspected open or depressed skull fracture
  • Any sign of basilar skull fracture (hemotypanum, Raccoon eyes, Battle’s sign, CSF oto or rhinorrhea)

Medium Risk Criteria (rules out clinically important brain injury)

  • Retrograde amnesia to event  ≥ 30 minutes
  • Dangerous mechanism (pedestrian struck by motor vehicle, ejection from motor vehicle, fall from > 3 feet or > 5 stairs)

NEXUS Head CT Instrument

  • Evidence of significant skull fracture
  • Scalp hematoma
  • Neurologic deficit
  • Altered level of alertness
  • Abnormal behavior
  • Coagulopathy
  • Persistent vomiting
  • Age ≥65 years

The Canadian CT Head Rule (CCHR) only applies to patients with an initial GCS of 13-15, witnessed loss of consciousness (LOC), amnesia to the head injury event, or confusion [18]. The study was only for patients > 16 years of age. Patients were excluded from the study if they had “minor head injuries” that didn’t even meet these criteria. Patients were also excluded if they had signs or symptoms of moderate or severe head injury, including GCS < 13, post-traumatic seizure, focal neurologic deficits, or coagulopathy. The CCHR was designed to identify clinically important injuries and injuries requiring neurosurgical intervention. A potential limitation of its use could be if one works in a practice environment where the standard of care is to identify all intracranial injuries versus only those that require acute intervention.

The NEXUS Head CT Instrument was developed and validated more recently to address some of the limitations of rules, including the CCHR, where the inclusion and exclusion criteria may preclude its application in over one-third of blunt head injury cases, as well as other rules that focused only on pediatric populations such as PECARN [19-22]. The NEXUS Instrument is a one-way decision instrument for patients of all ages to identify low-risk patients who do not require CT imaging. The developers of the tool acknowledge that although its sensitivity is 100%, it is no better than the equal 100% sensitivity of clinical judgment [23]. Therefore, the benefit of its use is limited to “ruling out” significant intracranial injuries and reducing unnecessary testing. The developers also highlight that the use of CT imaging provides little information on concussions and post-concussive syndromes and that negative imaging does not preclude concussive injuries that can result in long-term brain injury and impairment.

Case 3 Discussion

By applying both rules to the above case, the patient does not require imaging despite her transient loss of consciousness after the injury.

PECARN Pediatric Head Trauma Algorithm

Case 4

A 20-month-old female was going up some wooden stairs, slipped and fell down four stairs, and hit the back of her head on the wooden landing at the bottom of the stairs. She did not lose consciousness and cried immediately. According to her parents, she was consolable after a few minutes and acted normally. She has not vomited. On exam, she is well-appearing, alert, and has a normal neurologic exam. She is noted to have a left parietal hematoma measuring approximately 4×4 cm.

Should you obtain CT imaging of this child to rule out clinically significant head injury?

a-photo-of-a-20-month-old-female-child-(image generated by ideogram2.0)

PECARN Pediatric Head Trauma Algorithm

Age < 2
  • GCS < 15, palpable skull fracture, or signs of altered mental status
  • Occipital, parietal or temporal scalp hematoma; History of LOC≥5 sec; Not acting normally per parent or Severe Mechanism of Injury?
Age ≥ 2
  • GCS < 15, palpable skull fracture, or signs of altered mental status
  • History of LOC or history of vomiting or Severe headache or Severe Mechanism of Injury?

The PECARN (Pediatric Emergency Care Applied Research Network) Pediatric Head Trauma Algorithm was developed as a CDR to minimize unnecessary radiation exposure to young children. The estimated risk of lethal malignancy from a single head CT in a 1-year-old is 1 in 1000-1500 and decreases to 1 in 5000 in a 10-year-old [24]. Due to these risks, in addition to costs, length of stay and potential risks of procedural sedation, this CDR is widely employed given the frequency of pediatric head trauma ED visits. This CDR uses a prediction tree to assess risk, and unlike some other risk stratification tools, the PECARN group provides recommendations based on their definitions of acceptable risk levels. In the less than 2-year-old group, the rule was found to be 100% sensitive, with sensitivities ranging from 96.8%-100% sensitive in the greater than 2-year-old group [25,26].

This algorithm does have some complexity and ambiguity. It requires the practitioner to know what were considered signs of altered mental status and what were considered severe mechanisms of injury. In addition, certain paths of the decision tree lead to intermediate risk zones. In these cases, the recommendation is “observation versus CT,” allowing the ED physician to base their decision to image or not on numerous contributory factors, including physician experience, multiple versus isolated findings, and parental preference, among others.

Other pediatric head trauma CDRs have been derived and validated; however, in comparison trials, PECARN performed better than the other CDRs [1]. Of note, in this study, physician practice (without using a specific CDR) performed as well as PECARN with only slightly lower specificity.

Case 4 Discussion

The patient falls into an intermediate risk zone of clinically important brain injury. However, a sub-analysis of patients less than two years old with isolated scalp hematomas suggests that patients were at higher risk if they were < 3 months of age, had non-frontal scalp hematomas, large scalp hematomas (> 3cm), and had severe mechanism of injury [27]. Given the large hematoma in the case study patient and a severe mechanism of injury (a fall of > 3 feet in the under 2 yo age group), one should consider imaging due to these two additional higher risk factors.

PECARN Abdominal Trauma

  • Evidence of abdominal wall trauma/seatbelt sign or GCS < 14 with blunt abdominal trauma (if no, go to next point) – 5.4% risk of needing intra-abdominal injury intervention
  • Abdominal tenderness (if no, go to next point) – 1.4 % risk of intra-abdominal injury intervention
  • Thoracic wall trauma, complaints of abdominal pain, decreased breath sounds, vomiting – 0.7% risk of intra-abdominal injury intervention

The PECARN group has also developed a CDR, which was externally validated for pediatric blunt abdominal trauma [28,29]. This CDR uses a seven-point decision rule. If the patient does not have any of these findings, the patient would be considered “very low risk,” with a 0.1% risk of intra-abdominal injury intervention required. A study compared the PECARN CDR versus clinical suspicion and found that the CDR had significantly higher sensitivity (97.0% vs. 82.8% but lower specificity (42.5% vs. 78.7%) [30]. However, abdominal CTs were done in 33% of patients with clinical suspicion < 1%, meaning that even though clinical suspicion had higher specificity, this often did not translate into clinical practice. A recent external validation study supported the use of the CDR in decreasing CT use in pediatric patients at very low risk for clinically important intra-abdominal injuries [29].

NEXUS Chest Decision Instrument for Blunt Chest Trauma

NEXUS Chest was derived and validated for blunt chest trauma patients to identify very low-risk patients that do not require imaging [31,32].  It was developed only to rule out injury, not ruling it in. In other words, finding one or more NEXUS Chest criteria does not mean you must image that patient. The CDR creators suggest using NEXUS Chest only in patients for whom imaging was planned, then apply NEXUS Chest to determine whether one can safely forego imaging.

Pulmonary CDRs

Case 5

A 19-year-old female presents with sharp right flank pain and shortness of breath, which started suddenly the day before arrival. The pain is worse with deep inspiration but not related to exertion and not relieved with ibuprofen. She denies anterior chest pain, cough, and fever. She denies leg pain or swelling and recent travel, immobilization, trauma, or surgery. She has no anterior abdominal pain, no dysuria or hematuria, and no personal or family history of gallstones, kidney stones, or blood clots. She’s never had this pain before, has no significant past medical history, and her only medication is birth control pills. On exam, her vital signs are within normal range; she has normal cardiac and pulmonary exams, no costo-vertebral angle tenderness, no chest wall or abdominal tenderness, and no leg swelling.

Do you need to do any studies to evaluate this patient for a pulmonary embolism?

a-photo-of-a-19-year-old-female-patient-(image generated by ideogram2.0)

Pulmonary Embolism Rule-Out Criteria (PERC)

  • Age ≥ 50
  • Heart rate ≥ 100
  • O2 sat on room air < 95%
  • Prior history of venous thromboembolism
  • Trauma or surgery within 4 weeks
  • Hemoptysis
  • Exogenous estrogen
  • Unilateral leg swelling

The PERC CDR was originally derived and validated in 2004 and with a subsequent multi-study center validation in 2008 [33,34]. In the larger validation study, the rule was only applied in those patients with a pre-test probability of < 15%, therefore incorporating clinical gestalt before using the rule. As mentioned above, PERC is a one-way rule that tries to identify patients with low risk for pulmonary embolism (PE) so as not to require any testing. It does not imply that testing should be done for patients who do not meet criteria, and it is not meant for risk stratification, as opposed to the Wells and Geneva scores.

Case 5 Discussion

To apply the PERC CDR to the case, the ED physician pre-supposes a pre-test probability of < 15%. If the ED physician has a higher pre-test probability than that, the physician should not use the PERC CDR. If the ED physician in this case did indeed have a pre-test probability of < 15%, the case study patient would fail the rule-out due to her use of oral contraceptives. In that case, the ED physician would need to determine if he/she would do further testing, which could include a D-dimer, CT chest with contrast, ventilation/perfusion scan, or lower extremity Doppler studies to evaluate for deep vein thromboses (DVTs). The PERC CDR gives no guidance in this case.

Wells and Revised Geneva Score for Pulmonary Embolism (PE)

Wells’ Criteria for Pulmonary Embolism

Point Value

Clinical signs and symptoms of DVT

+3

PE is #1 diagnosis, or equally likely

+3

Heart rate > 100

+1.5

Immobilization at least 3 days, or Surgery in the Previous 4 weeks

+1.5

Previous, objectively diagnosed PE or DVT

+1.5

Hemoptysis

+1

Malignancy w/ Treatment within 6 mo, or palliative

+1

Geneva Score (Revised) for Pulmonary Embolism

Point Value

Risk factors

Age > 65

+1

 

Previous DVT or PE

+3

 

Surgery (under general anesthesia) or lower limb fracture in past 1 month

+2

 

Active malignant condition

+2

Symptoms

Unilateral lower limb pain

+3

 

Hemoptysis

+2

Signs

Heart rate < 75

0

 

Heart rate 75 – 94

+3

 

Heart rate ≥ 95

+5

 

Pain on lower limb deep venous palpation and unilateral edema

+4

The Wells’ Criteria for PE is a risk stratification score with different point values assigned to different criterion. Its purpose is to identify patients with a lower PE risk to avoid unnecessary testing and the associated risks and costs [35]. The criteria have been validated in the ED setting [36]. The initial study used a three-tier model to classify patients as low, medium, or high risk. Subsequent studies have been done to apply a simplified version of the Wells’ Criteria and also to use the Wells’ Criteria along with D-dimer testing in a dichotomous manner (two-tier model) where a score of 4 or less (“PE Unlikely” group) combined with a negative D-dimer would achieve sufficiently low probability of PE so as not to pursue further work-up [37-39].  This two-tier model is supported by the American College of Physicians (ACEP) Clinical Guidelines [40]. A two-tier model using a cut-off of less than 6 for low-risk was also studied in pregnant patients with a negative predictive value of 100% [41].  

The original Geneva score included chest radiography and an ABG, whereas the revised score (rGeneva) uses only clinical criteria [42]. A patient with an rGeneva score of 0-3 is considered low risk with a < 10% prevalence of PE.  A score of 4-10 identifies intermediate-risk patients, and a score of 11+ is high risk (>60% prevalence or PE).

The Wells and rGeneva scores have been compared and found to have overall similar accuracy [43-45]. These PE risk stratification tools are meant to be applied to patients with concern for PE as a diagnosis. If PE is not under consideration, the tools should not be applied. Practically speaking, for many ED physicians, these tools are used to help risk stratify patients to identify those who are very low-risk such that no testing should be done, low to intermediate risk such that D-dimer testing would be a useful diagnostic tool, or high risk such that even if a D-dimer were negative, the post-test probability would remain high enough that further testing should be pursued. One recent study found that physician gestalt performed better than the Wells or rGeneva scores [45]. However, guidelines from the Clinical Practice Committee of the American College of Physicians (ACP) were published in 2015 that outline best practice advice including advocating that clinicians should use validated CDRs to estimate pre-test probability in patients in whom acute PE is being considered [46].

YEARS Algorithm for Pulmonary Embolism

The YEARS Algorithm was derived in 2017 and subsequently validated in studies in 2018 and 2021 [47-49]. It consists of the three most predictive criteria of the Well’s Score for PE and incorporates variable D-dimer thresholds, depending on the number of criteria fulfilled. It has the benefit of reducing the use of CT Pulmonary Angiogram by more broadly utilizing the results of D-dimer testing for selected patients. Additionally, a pregnancy-adapted algorithm was developed in 2019, which may be useful for clinicians struggling with the challenge of excluding PE in this sub-group, which has both a higher risk of PE and of radiation exposure to the fetus of performing the “gold standard” test which is considered a CT angiogram [50]. A recent study found that using the YEARS algorithm in combination with an age-adjusted D-dimer strategy was non-inferior to conventional diagnostic strategies and decreased chest imaging by 14% [51].

Pneumonia Severity Index (PSI) Score

The PSI Score estimates mortality for adult patients with community-acquired pneumonia (CAP). It is recommended as a Clinical Practice Guideline by the American Thoracic Society and Infectious Disease Society to use the PSI, in addition to clinical judgment, to determine the need for hospitalization in patients with CAP [52]. Although it has more variables than the CURB-65 Score, it was found to identify larger proportions of patients as low risk and found to have better discriminative power in predicting mortality. It includes variables such as age and sex as well as vital signs, co-morbidities, lab values, and imaging findings, which may limit its use in some resource-limited settings.

Ottawa COPD Risk Scale

The Ottawa COPD Risk Scale predicts 30-day mortality or serious adverse events in ED patients with COPD [53]. It was developed and validated to assist with disposition decisions to avoid admitting low-risk patients suitable for discharge and to avoid discharging high-risk patients [54]. It incorporates elements of the patient’s medical history and exam in the ED as well as testing, including an EKG, chest X-ray, hemoglobin, urea, and CO2.

Cardiac CDRs

Case 6

A 50-year-old male presents to the ED complaining of chest pain for two days. His pain is substernal and non-radiating. He described it as a tightness and is not related to exertion. He has no associated shortness of breath, nausea, or diaphoresis. No cough or fever. He’s never had this pain before. He has a history of hypertension but no other cardiac risk factors. His exam in the ED is normal, and his EKG and initial troponin are normal.

Does this patient require additional cardiac workup in the ED or admission to the hospital for further workup? Can this patient be safely discharged for outpatient follow-up?

a-photo-of-a-50-year-old-male-patient-(image generated by ideogram2.0)

HEART Score for Cardiac Events

HEART Score

 

Points

History

Highly suspicious

+2

 

Moderately suspicious

+1

 

Slightly suspicious

0

EKG

Significant ST depression

+2

 

Non specific repolarization disturbance

+1

 

Normal

  0

Age

≥ 65

+2

 

45-65

+1

 

≤ 45

0

Risk Factors (include: hypercholesterolemia, hypertension, diabetes mellitus, cigarette smoking, positive family history, obesity)

≥ 3 risk factors or history of atherosclerotic disease

+2

 

1-2 risk factors

+1

 

No risk factors known

0

Troponin

≥ 3× normal limit

+2

 

1-3× normal limit

+1

 

≤ normal limit

0

The HEART Score is used to risk stratify chest pain patients in the ED to identify those at risk for major adverse cardiac events (MACE) within six weeks [55]. In the HEART Score, patients with a low risk (score between 0 and 3) indicate a less than 2% risk of major adverse cardiovascular events (MACE) within six weeks. The HEART Score differs from the Thrombolysis in Myocardial Infarction (TIMI) and Global Registry of Acute Coronary Events (GRACE) scores as those scores measure the risk of death for patients with diagnosed acute coronary syndromes (ACS) rather than identifying patients who have cardiac-related chest pain in the first place [56,57]. Additionally, even with low TIMI scores for those diagnosed with ACS in the ED, there is still a 4.7% risk of a bad outcome [56]. This may be of little utility to the ED physician, who finds this risk level unacceptable.

Case 6 Discussion

This patient’s HEART Score is 3 if the physician considers the history “moderately suspicious.” The patient is at low risk for a major cardiac event in the next six weeks so that the ED physician could consider outpatient follow-up. Again, the risk stratification scores are not prescriptive, however. The clinician must make decisions based on his/her judgment, available resources, and comfort with certain levels of risk.

Emergency Department Assessment of Chest Pain Score (EDACS)

Similar to the HEART Score, the EDACS is used to further risk stratify patients with chest pain or other anginal symptoms requiring evaluation for possible acute coronary syndrome who may be potentially low risk and appropriate for early discharge from the emergency department [58]. It should only be applied in patients without ongoing chest pain. The score was 99-100% sensitive in the original derivation paper, and some studies showed it to be more sensitive than the HEART score and better at identifying more low-risk patients [59,60]. That said, a more recent meta-analysis reported a pooled sensitivity of only 96.1%, which may not be considered adequately sensitive by some providers or in some practice environments [61].

Ottawa Heart Failure Risk Score

The Ottawa Heart Failure Risk Scale (OHFRS) was derived in 2013 and validated in 2017 in Canada [62, 63]. It identifies ED patients with heart failure (HF) at high risk for serious adverse events, including death, MI, and the need for ICU/intubation. It is to be used for ED patients presenting with HF exacerbation who have responded to treatment in the ED to help clinicians determine whether admission might be warranted versus discharge for low-risk patients. The study authors looked at the performance of the CDR both with and without a Quantitative NT-proBNP diagnostic test. They found the CDR was valuable even without the availability of this test, which might improve its usefulness in different resource settings. That said, regional practice patterns should be considered when applying this score, such as differences overall in heart failure admission rates.

Atrial Fibrillation – the CHA2DS2-VASc and HAS-BLED Scores

The main clinical decision instruments regarding atrial fibrillation (afib) relate to whether or not to anticoagulate a patient in afib, weighing the risk of stroke without anticoagulation versus the risk of a major bleeding event. The CHA2DS2-VASc Score was developed in an era where Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) are available in higher-resource settings, in addition to traditional warfarin, and in light of more recent evidence regarding the lack of efficacy and safety of aspirin for stroke prevention in afib [64,65]. The score is simple to use with variables of age, sex, and the patient’s medical history. The European Society of Cardiology guidelines recommend using the score to identify truly low-risk patients (0 for males or 1 for females) who do not need anticoagulation therapy [66]. The American Heart Association and American College of Cardiology guidelines also endorse using the CHA2DS2-VASc score as the stroke risk assessment tool of choice [67].

In addition to considering the risk of stroke in patients with afib, however, one also has to consider the risk of bleeding due to taking anticoagulants. Unfortunately, many risk factors for the former are also risk factors for the latter. The score that performs best for identifying the risk of bleeding is the HAS-BLED score [68-70]. The HAS-BLED authors note that while it does not identify absolute cut-offs for when not to use anticoagulants, it does help identify some risk factors that could be avoided or reversed, for example, by controlling hypertension or avoiding alcohol use or other medications that may predispose to bleeding. The decision of whether or not to anticoagulated a patient in afib is complex, but these CDRs provide some objective assessment of risk to inform decision-making and educate patients, and include them in shared-decision making.

Abdominal CDRs

Gastrointestinal Bleeding

Case 7

A 30-year-old male presents to the ED with nausea, vomiting, and epigastric discomfort for one day. He vomited multiple times, initially non-bloody, then developed some blood in the vomit during the last two episodes, which he quantified as a teaspoon in each. He denies melena or hematochezia. He has no diarrhea, fever, or syncope. He denies a history of liver or heart problems. On exam, he has normal vital signs with an initial blood pressure of 128/78 mmHg in the ED, and his abdomen is non-tender. His hemoglobin is 13.5, and his BUN is 5.

Does this patient need admission for further monitoring or evaluation of his upper GI bleed?

The image was produced by using ideogram 2.0.

Glasgow-Blatchford Bleeding Score (GBS)

  • Hemoglobin < 13 for men or < 12 for women
  • BUN > 6.5
  • Initial systolic blood pressure < 110
  • Heart rate ≥ 100
  • Melena present
  • Recent syncope
  • Hepatic disease history
  • Cardiac failure

The Glasgow-Blatchford Bleeding Score (GBS) uses clinical information and some diagnostic testing to risk stratify upper GI bleeding patients[71,72]. It should not be used for lower GI bleeding patients or patients in whom the source of GI bleeding is unclear. A score of 0 is considered low risk. Any score higher than 0 is considered high risk for needing a medical intervention of transfusion, endoscopy, or surgery; therefore, any of the above criteria would be considered high risk. The tool assigns different point values to different gradations of the variables present to a possible highest possible score of 29. The GBS has performed better than other CDRs in predicting patients likely to need hospital-based intervention or are at risk for mortality [73].

Case 7 Discussion

The patient does not meet any of the GBS criteria and would be considered low-risk. Based on this risk stratification, the patient does not demonstrate any signs of lower GI bleeding and could likely be safely discharged home.

Oakland Score for Safe Discharge After Lower GI Bleed

Similar to the GBS Score, the Oakland Score helps identify low-risk patients with lower GI bleeding who are candidates for outpatient management. It is simple to use in most settings and includes age, sex, history, physical exam findings in the ED, and hemoglobin level [74,75].

Appendicitis - Alvarado Score and Pediatric Appendicitis Risk Calculator (pARC)

The Alvarado Score was developed to predict the likelihood of acute appendicitis in patients with abdominal pain [76]. It utilizes a combination of signs, symptoms, and a WBC count with differential to create a risk score. The score is best utilized to avoid unnecessary CT imaging in very low-risk patients or even potentially in very high-risk patients, particularly in low-resource settings where CT is not commonly available [77]. In a study comparing the Alvarado Score with another CDR for pediatric appendicitis, the Pediatric Appendicitis Score, the gestalt of a pediatric surgeon was found to be higher than either scoring system; however, the Alvarado Score may be useful in emergency settings without experienced clinicians [78].

The pARC was also developed specifically for pediatric patients aged 5-18 to identify risk for acute appendicitis [79]. It may be used to help determine the need for advanced imaging and identify low-risk patients who could be observed or discharged from the ED with follow-up or return precautions. The Alvarado Score relies on signs, symptoms, and the availability of WBC and neutrophil counts. In its validation study, it performed better than the Pediatric Appendicitis Score [80].

STONE Score for Uncomplicated Ureteral Stone

The STONE Score was developed to identify patients with a high likelihood of uncomplicated ureterolithiasis who could be managed empirically, minimizing the use of CT or possibly using a low radiation CT protocol [81-83]. It has simple demographic and symptom-based variables with the addition of a urine dipstick; it is, therefore, easy to apply across resource settings. A high STONE Score can decrease the likelihood of an alternative diagnosis to < 2%, potentially limiting unnecessary costs and radiation exposure associated with CT imaging. Ultrasound demonstrating hydronephrosis, in addition to the score, can further increase the likelihood of a stone [84]. Given the increased availability and use of point-of-care ultrasound (POCUS) in emergency settings, using the STONE score in combination with ultrasound is a prudent approach to avoid CT use. A caveat to the STONE score is that it should not be used in ill-appearing patients or those with signs or symptoms suggestive of a possible complicated ureterolithiasis, for example, if there is evidence of a concomitant infection.

Neurologic CDRs

Case 8

A 24-year-old woman presents with a headache that began three hours before arrival at the ED. The patient was at rest when the headache started. The headache was not described as a “thunderclap,” but it did reach maximum severity within the first 30 minutes. The headache is generalized and rated 10/10. She denies head trauma, weakness, numbness, and tingling in her extremities. She denies visual changes, changes in speech, and neck pain. She has not taken anything for the headache. She does not have a family history of cerebral aneurysms or polycystic kidney disease. She had a normal neurologic exam and normal neck flexion during the physical exam.

Should you do a head CT and/or a lumbar puncture to evaluate for a sub-arachnoid hemorrhage in this patient?

a-photo-of-a-24-year-old-woman-sitting-on-an-ed-(mage generated by ideogram2.0)

Ottawa SAH Rule

Investigate if ≥1 high-risk variable is present:

  • Age ≥ 40
  • Neck pain or stiffness
  • Witnessed loss of consciousness
  • Onset during exertion
  • Thunderclap headache (instantly peaking pain)
  • Limited neck flexion on exam

A CDR to determine the risk for subarachnoid hemorrhage (SAH) was derived and externally validated in a single study [85,86]. The purpose of the CDR was to identify individuals at high risk for SAH. This included those experiencing acute non-traumatic headaches that reached maximal intensity within one hour and had normal neurological examinations. Notably, the rule consists of several criteria for inclusion and exclusion, which the emergency department physician must understand. Additionally, it was derived only for patients aged 16 years and older. The study authors note that the CDR is to identify patients with SAH; it is not an acute headache rule. In the validation study, of over 5000 ED visits with acute headaches, only 9% of those met the inclusion criteria [86]. Additionally, clinical gestalt plays a significant role as the authors recommend not applying the CDR to individuals who are at ultra-high risk with a pre-test probability of SAH greater than 50%.

The Ottawa SAH Rule was 100% sensitive but did not reduce testing compared to current practice [85]. The authors state that the rule’s value would be standardizing physician practice and avoiding the relatively high rate of missed sub-arachnoid hemorrhages.

Case 8 Discussion

By applying the Ottawa SAH Rule, this patient is low risk and does not require further investigation for a SAH.

Canadian Transient Ischemic Attack (TIA) Score

The Canadian TIA Score was developed to identify patients at high risk for stroke in the next seven days after a TIA [87,88]. It is calculated based on clinical findings and ED testing, including an EKG, CT, platelet count, and glucose. The validation study also looked at the outcome of carotid endarterectomy or carotid artery stenting within seven days and found that the Canadian TIA Score outperformed the ABCD2 risk stratification tool. It is unclear yet how the application of the tool will impact ED practice, which will likely depend on many factors, including inpatient versus outpatient access to resources. The validation study authors suggest, “The optimal management pathway at the local or regional level can be determined on the basis of the expected risk at a given risk category (for example, same day computed tomography with routine follow-up for patients at low risk, computed tomography angiography and rapid follow-up for those at medium risk, and neurology consultation in the emergency department for those at high risk) [88].”

Other CDRs

San Francisco Syncope Rule

The San Francisco Syncope Rule uses five factors to identify patients who are at high risk of serious outcomes at seven days, including a history of congestive heart failure, hematocrit < 30%, abnormal EKG, shortness of breath, and systolic BP < 90mmHg at triage. In its initial derivation and validation studies, it was found to have 92% and 98% sensitivity, respectively [89, 90]. Its use is controversial, however, due to inconsistent validation studies where it has not performed as well [91,92]. A systematic review of the literature from 2011 suggested that “the probability of a serious outcome given a negative score with the San Francisco Syncope Rule was 5% or lower, and the probability was 2% or lower when the rule was applied only to patients for whom no cause of syncope was identified after initial evaluation in the emergency department [93].” Although there is no consensus on using this tool to safely discharge patients with syncope home if they do not meet these criteria, patients with criteria would be considered a higher risk, possibly warranting observation, admission, and/or further diagnostic studies.

Centor Score for Streptococcal Pharyngitis

The Centor Score is a risk stratification tool that looks at clinical criteria that suggest a greater likelihood of strep pharyngitis, which may prompt the ED physician to prescribe antibiotics [94]. It was initially designed for use in adults. However, a modified score has been validated for use in children > 2 years of age and adults that includes age criteria, as strep pharyngitis is a more common condition in children [95,96]. With a score of 4 or more points, the probability of strep is greater than 50%, and some would advocate for empiric antibiotics in this group to reduce suppurative (peritonsillar abscess, cervical lymphadenitis, and mastoiditis) and non-suppurative (e.g., acute rheumatic fever) complications of strep pharyngitis and shorten the duration of clinical symptoms and as well as to reduce transmission [97]. Rapid antigen detection tests have been found to have a sensitivity of between 70 and 90% and a specificity of ≥95% [97]. Some authors recommend rapid antigen detection testing (RADT) only for children with high clinical scores or if the results of the standard throat culture will not be available for more than 48 hours [97,98]. Studies have found that tonsillar exudates conferred the highest odds of strep infection [96,99].

Conclusion

Clinical Decision Rules (CDRs) or Instruments are increasingly being used to assist ED clinicians in navigating complex decision-making regarding diagnostic testing, clinical care, and disposition determination of emergency patients. These tools have the potential to supplement clinician gestalt, maximize the use of limited and expensive resources (e.g., inpatient beds, CTs), and minimize the use of possibly unnecessary costly or dangerous testing or treatments (e.g., CTs, anticoagulants).

While CDRs are a valuable adjunct to the emergency clinician, ED providers must carefully apply these based on validation cohorts representative of the clinician’s patient population and carefully consider the inclusion and exclusion criteria in the studies. CDRs should not supplant physician critical decision-making based on individualized patient-centered factors and circumstances including resources available, ability to establish outpatient follow-up, and shared-decision making with informed patients. CDRs may be particularly valuable for less experienced clinicians who are learning to identify patient characteristics, symptoms, physical exam findings, risk factors and testing that will help them diagnose and manage complex emergency patients in variable practice environments.

Author

Picture of Stacey Chamberlain

Stacey Chamberlain

Dr. Stacey Chamberlain is a board certified emergency physician who is a Professor in the Department of Emergency Medicine at the University of Illinois at Chicago (UIC). She also serves as the Director of the Global Emergency Medicine Fellowship Program and the Co-Director of the Social Emergency Medicine Fellowship Program. In addition to her work in Emergency Medicine, she is the Director of Academic Programs at the UIC Center for Global Health. In this role, she oversees the Global Medicine (GMED) Program for UIC medical students and the graduate global health certificate programs. Dr. Chamberlain has done clinical, educational, public-health, disaster-response, and emergency medicine development work, including working with several globally-focused NGOs, spanning five continents. Her global health work focuses on capacity building in emergency care in Uganda.

Listen to the chapter

2018 version of this topichttps://iem-student.org/clinical-decision-rules/

References

  1. Easter JS, Bakes K, Dhaliwal J, Miller M, Caruso E, Haukoos JS. Comparison of PECARN, CATCH, and CHALICE rules for children with minor head injury: a prospective cohort study. Ann Emerg Med. 2014 Aug; 64(2):145-52, 152.e1-5. doi: 10.1016/j.annemergmed.2014.01.030. Epub 2014 Mar 11.
  2. Lucassen W, Geersing GJ, Erkens PMG, Reitsma JB, Moons KGM, Büller H, van Weert HC. Clinical decision rules for excluding pulmonary embolism: a meta-analysis. Ann Intern Med. 2011 October 4; 155(7): 448–460. doi: 10.7326/0003-4819-155-7-201110040-00007
  3. Kline JA, Courtney DM, Kabrhel C, Moore CL, Smithline HA, Plewa MC, Richman PB, O’Neil BJ, Nordenholz K. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008 May; 6(5):772-80. doi: 10.1111/j.1538-7836.2008.02944.x. Epub 2008 Mar 3.
  4. Ferreira G, Carson JL. Clinical prediction rules for the diagnosis of pulmonary embolism. Am J Med. 2002; 113:337–338.
  5. Childs JD and Cleland Development and application of clinical prediction rules to improve decision making in physical therapist practice. Physical Therapy. 2006 January; 86(1):122-131.
  6. Green SM. When do clinical decision rules improve patient care? Annals of Emergency Medicine. 2014 March;63(3):373.
  7. Emergency Medicine Cases. Episode 56 The Stiell Sessions: Clinical Decision Rules and Risk Scales. Available online at: http://emergencymedicinecases.com/episode-56-stiell-sessions-clinical-decision-rules-risk-scales/.   Accessed Dec 2, 2015.
  8. Green SM, Schriger DL, Yealy, DM. Methodologic standards for interpreting clinical decision rules in emergency medicine: 2014 Update. Annals of Emergency Medicine. 2014 Sept; 64(3): 286-291.
  9. Seaberg DC, Jackson R. Clinical decision rule for knee radiographs. Am J Emerg Med. 1994; 12: 541-543.  
  10. Stiell IG, Wells GA, Hoag RH, Sivilotti ML, Cacciotti TF, Verbeek PR, Greenway KT, McDowell I, Cwinn AA, Greenberg GH, Nichol G, Michael JA. Implementation of the Ottawa knee rule for the use of radiography in acute knee injuries. JAMA.1997; 278: 2075-2079. http://dx.doi.org/10.1001/jama.278.23.2075
  11. Bachmann LM, Haberzeth S, Steurer J, ter Riet G. The accuracy of the Ottawa knee rule to rule out knee fractures: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2): 121-4.
  12. Stiell IG, Wells GA, Hoag RH, et al. Implementation of the Ottawa Knee Rule for the use of radiography in acute knee injuries. 1997; 278(23): 2075-2079. doi:10.1001/jama.1997.03550230051036.
  13. Bulloch B, Neto G, Plint A, Lim R, Lidman P, Reed M, Nijssen-Jordan C, Tenenbein M, Klassen TP, Bhargava R; Pediatric Emergency Researchers of Canada. Validation of the Ottawa Knee Rule in children: a multicenter study. Ann Emerg Med. 2003 Jul; 42(1): 48-55.
  14. Dowling S, Spooner CH, Liang Y, Dryden DM, Friesen C, Klassen TP, Wright RB. Accuracy of Ottawa Ankle Rules to exclude fractures of the ankle and midfoot in children: a meta-analysis. Acad Emerg Med. 2009 Apr; 16(4): 277-87. doi: 10.1111/j.1553-2712.2008.00333.x. Epub 2009 Feb 2.
  15. Hoffman JR, Wolfson AB, Todd K, Mower WR. Selective cervical spine radiography in blunt trauma: methodology of the National Emergency X-Radiography Utilization Study (NEXUS). Ann Emerg Med. 1998 Oct; 32(4): 461-9.
  16. Stiell IG, Wells GA, Vandemheen KL, Clement CM, Lesiuk H, De Maio VJ, Laupacis A, Schull M, McKnight RD, Verbeek R, Brison R, Cass D, Dreyer J, Eisenhauer MA, Greenberg GH, MacPhail I, Morrison L, Reardon M, Worthington J. The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA. 2001 Oct 17; 286(15): 1841-8. PubMed PMID: 11597285
  17. Stiell, IG, Clement CM, McKnight RD, Brison R, Schull MJ, et al. The Canadian C-spine rule versus the NEXUS low-risk criteria in patients with trauma. New England Journal of Medicine. 2003; 349(26): 2510-2518.
  18. Stiell, IG, Wells GA, Vandemheen K. et al, The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001; 357: 1391–1396.
  19. Harnan SE, Pickering A, Pandor A, Goodacre SW. Clinical decision rules for adults with minor head injury: a systematic review. J Trauma. 2011 Jul; 71(1): 245-51. doi: 10.1097/TA.0b013e31820d090f.
  20. Bouida W, Marghli S, Souissi S, Ksibi H, Methammem M, et al. Prediction value of the Canadian CT head rule and the New Orleans criteria for positive head CT scan and acute neurosurgical procedures in minor head trauma: a multicenter external validation study. Ann Emerg Med. 2013 May;61(5):521-7. doi:10.1016/j.annemergmed.2012.07.016. Epub 2012 Aug 22.
  21. Mower WR, Hoffman JR, Herbert M, Wolfson AB, Pollack CV Jr, Zucker MI; NEXUS II Investigators. Developing a decision instrument to guide computed tomographic imaging of blunt head injury patients. J Trauma. 2005 Oct;59(4):954-9. doi: 10.1097/01.ta.0000187813.79047.42. PMID: 16374287.
  22. Mower WR, Gupta M, Rodriguez R, Hendey GW. Validation of the sensitivity of the National Emergency X-Radiography Utilization Study (NEXUS) Head computed tomographic (CT) decision instrument for selective imaging of blunt head injury patients: An observational study. PLoS Med. 2017 Jul 11;14(7):e1002313. doi: 10.1371/journal.pmed.1002313. PMID: 28700585; PMCID: PMC5507397.
  23. NEXUS CT Head Instrument. Creator Insights. Dr. William R. Mower. Accessed at https://www.mdcalc.com/calc/10423/nexus-head-ct-instrument#creator-insights on November 11, 2022.
  24. Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001 Feb; 176(2): 289-96.
  25. Kuppermann N, Holmes JF, Dayan PS, Hoyle JD Jr, Atabaki SM, et al. Pediatric Emergency Care Applied Research Network (PECARN). Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet. 2009 Oct 3; 374(9696): 1160-70. doi: 10.1016/S0140-6736(09)61558-0. Epub 2009 Sep 14. Erratum in: Lancet. 2014 Jan 25;383(9914):308.
  26. Schonfeld D, Bressan S, Da Dalt L, Henien MN, Winnett JA, Nigrovic LE. Pediatric Emergency Care Applied Research Network head injury clinical prediction rules are reliable in practice. Arch Dis Child. 2014 May; 99(5): 427-31. doi: 10.1136/archdischild-2013-305004. Epub 2014 Jan 15.
  27. Dayan PS, Holmes JF, Schutzman S et al. Risk of traumatic brain injuries in children younger than 24 months with isolated scalp hematomas. Ann Emerg Med. 2014; 64: 153–162.
  28. Holmes JF1, Lillis K, Monroe D, Borgialli D, Kerrey BT, Mahajan P, et al. Identifying children at very low risk of clinically important blunt abdominal injuries. Ann Emerg Med. 2013 Aug; 62(2): 107-116.e2. doi: 10.1016/j.annemergmed.2012.11.009. Epub 2013 Feb 1.
  29. Springer E, Frazier SB, Arnold DH, Vukovic AA. External validation of a clinical prediction rule for very low risk pediatric blunt abdominal trauma. Am J Emerg Med. 2019 Sep;37(9):1643-1648. doi: 10.1016/j.ajem.2018.11.031. Epub 2018 Nov 23. PMID: 30502218.
  30. Mahajan P, Kuppermann N, Tunik M, Yen K, Atabaki SM, et al. Comparison of clinician suspicion versus a clinical prediction rule in identifying children at risk for intra-abdominal injuries after blunt torso trauma. Acad Emerg Med. 2015 Sep; 22(9): 1034-41. doi: 10.1111/acem.12739. Epub 2015 Aug 20.
  31. Rodriguez RM, Hendey GW, Mower W, Kea B, Fortman J, Merchant G, Hoffman JR. Derivation of a decision instrument for selective chest radiography in blunt trauma. J Trauma. 2011 Sep;71(3):549-53. doi: 10.1097/TA.0b013e3181f2ac9d. PMID: 21045745.
  32. Rodriguez RM, Anglin D, Langdorf MI, Baumann BM, Hendey GW, Bradley RN, Medak AJ, Raja AS, Juhn P, Fortman J, Mulkerin W, Mower WR. NEXUS chest: validation of a decision instrument for selective chest imaging in blunt trauma. JAMA Surg. 2013 Oct;148(10):940-6. doi: 10.1001/jamasurg.2013.2757. Erratum in: JAMA Surg. 2013 Dec;148(12):1086. PMID: 23925583.
  33. Kline JA, Mitchell AM, Kabrhel C, et al. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004; 2: 1247-1255.
  34. Kline JA, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost 2008; 6: 772–80. (PMID: 18318689).
  35. Wells PS, Anderson DR, Rodger M, Stiell I, Dreyer JF, Barnes D, Forgie M, Kovacs G, Ward J, Kovacs MJ. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med. 2001 Jul 17; 135(2): 98-107. PubMed PMID: 11453709.
  36. Wolf SJ, McCubbin TR, Feldhaus KM, Faragher JP, Adcock DM. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med. 2004 Nov; 44(5): 503-10. PubMed PMID: 15520710.
  37. Douma RA, Gibson NS, Gerdes VEA, Büller HR, et al. Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. Thromb Haemost. 2009; 101(1): 197-200 (ISSN: 0340-6245)
  38. Wells PS, Anderson DR, Rodger M, et. al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000 Mar; 83(3): 416-20.
  39. Writing Group for the Christopher Study Investigators. Effectiveness of Managing Suspected Pulmonary Embolism Using an Algorithm Combining Clinical Probability, D-Dimer Testing, and Computed Tomography. 2006; 295(2): 172-179. doi:10.1001/jama.295.2.172.
  40. American College of Emergency Physicians. Evaluation and Management of Adult Emergency Department Patients with Suspected Pulmonary Embolism (January 2011): Complete Clinical Policy on Suspected Pulmonary Embolism. Available online: http://www.acep.org/MobileArticle.aspx?id=80332&parentid. Accessed Dec 2, 2015.
  41. O’Connor C, Moriarty J, Walsh J, Murray J, Coulter-Smith S, Boyd W. The application of a clinical risk stratification score may reduce unnecessary investigations for pulmonary embolism in pregnancy. J Matern Fetal Neonatal Med. 2011 Dec.; 24(12): 1461-4.
  42. Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006 Feb 7; 144(3): 165-71. PubMed PMID: 16461960.
  43. Klok FA, Kruisman E, Spaan J, Nijkeuter M, Righini M, et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost. 2008 Jan; 6(1): 40-4. Epub 2007 Oct 29.
  44. Ceriani E, Combescure C, Le Gal G, Nendaz M, Perneger T, et al. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost. 2010 May; 8(5): 957-70. doi: 10.1111/j.1538-7836.2010.03801.x. Epub 2010 Feb 2.
  45. Penaloza A, Verschuren F, Meyer G, Quentin-Georget S, Soulie C, et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Ann Emerg Med. 2013 Aug;62(2):117-124.e2. doi: 10.1016/j.annemergmed.2012.11.002. Epub 2013 Feb 21.
  46. Raja AS, Greenberg JO, Qaseem A, Denberg TD, Fitterman N, et al. Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2015 Nov 3; 163(9): 701-11. doi: 10.7326/M14-1772. Epub 2015 Sep 29.
  47. Van der Hulle T, Cheung WY, Kooij S, Beenen LFM, van Bemmel T, van Es J, Faber LM, Hazelaar GM, Heringhaus C, Hofstee H, Hovens MMC, Kaasjager KAH, van Klink RCJ, Kruip MJHA, Loeffen RF, Mairuhu ATA, Middeldorp S, Nijkeuter M, van der Pol LM, Schol-Gelok S, Ten Wolde M, Klok FA, Huisman MV; YEARS study group. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017 Jul 15;390(10091):289-297. doi: 10.1016/S0140-6736(17)30885-1. Epub 2017 May 23. Erratum in: Lancet. 2017 Jul 15;390(10091):230. PMID: 28549662.
  48. Kabrhel C, Van Hylckama Vlieg A, Muzikanski A, Singer A, Fermann GJ, Francis S, Limkakeng A, Chang AM, Giordano N, Parry B. Multicenter Evaluation of the YEARS Criteria in Emergency Department Patients Evaluated for Pulmonary Embolism. Acad Emerg Med. 2018 Sep;25(9):987-994. doi: 10.1111/acem.13417. PMID: 29603819.
  49. Freund Y, Chauvin A, Jimenez S, et al. Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial. JAMA. 2021;326(21):2141–2149. doi:10.1001/jama.2021.20750
  50. Van der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, van Bemmel T, Bertoletti L, Couturaud F, van Dooren YPA, Elias A, Faber LM, Hofstee HMA, van der Hulle T, Kruip MJHA, Maignan M, Mairuhu ATA, Middeldorp S, Nijkeuter M, Roy PM, Sanchez O, Schmidt J, Ten Wolde M, Klok FA, Huisman MV; Artemis Study Investigators. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism. N Engl J Med. 2019 Mar 21;380(12):1139-1149. doi: 10.1056/NEJMoa1813865. PMID: 30893534.
  51. Freund Y, Chauvin A, Jimenez S, Philippon AL, Curac S, Fémy F, Gorlicki J, Chouihed T, Goulet H, Montassier E, Dumont M, Lozano Polo L, Le Borgne P, Khellaf M, Bouzid D, Raynal PA, Abdessaied N, Laribi S, Guenezan J, Ganansia O, Bloom B, Miró O, Cachanado M, Simon T. Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial. JAMA. 2021 Dec 7;326(21):2141-2149. doi: 10.1001/jama.2021.20750. PMID: 34874418; PMCID: PMC8652602.
  52. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST. PMID: 31573350; PMCID: PMC6812437.
  53. Stiell IG, Clement CM, Aaron SD, Rowe BH, Perry JJ, Brison RJ, Calder LA, Lang E, Borgundvaag B, Forster AJ, Wells GA. Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. CMAJ. 2014 Apr 1;186(6):E193-204. doi: 10.1503/cmaj.130968. Epub 2014 Feb 18. PMID: 24549125; PMCID: PMC3971051.
  54. Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Brinkhurst J, Wells GA. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department. CMAJ. 2018 Dec 3;190(48):E1406-E1413. doi: 10.1503/cmaj.180232. PMID: 30510045; PMCID: PMC6258211.
  55. Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008 Jun; 16(6): 191-6. PubMed PMID: 18665203; PubMed Central PMCID: PMC2442661.
  56. Antman EM, Cohen M, et. al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000 Aug 16; 284(7): 835-42.
  57. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006 Nov 25; 333(7578): 1091. Epub 2006 Oct 10. PubMed PMID: 17032691; PubMed Central PMCID: PMC1661748.
  58. Than M, Flaws D, Sanders S, Doust J, Glasziou P, Kline J, Aldous S, Troughton R, Reid C, Parsonage WA, Frampton C, Greenslade JH, Deely JM, Hess E, Sadiq AB, Singleton R, Shopland R, Vercoe L, Woolhouse-Williams M, Ardagh M, Bossuyt P, Bannister L, Cullen L. Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol. Emerg Med Australas. 2014 Feb;26(1):34-44. doi: 10.1111/1742-6723.12164. Epub 2014 Jan 15. PMID: 24428678.
  59. Than MP, Pickering JW, Aldous SJ, Cullen L, Frampton CM, Peacock WF, Jaffe AS, Goodacre SW, Richards AM, Ardagh MW, Deely JM, Florkowski CM, George P, Hamilton GJ, Jardine DL, Troughton RW, van Wyk P, Young JM, Bannister L, Lord SJ. Effectiveness of EDACS Versus ADAPT Accelerated Diagnostic Pathways for Chest Pain: A Pragmatic Randomized Controlled Trial Embedded Within Practice. Ann Emerg Med. 2016 Jul;68(1):93-102.e1. doi: 10.1016/j.annemergmed.2016.01.001. PMID: 26947800.
  60. Mark DG, Huang J, Chettipally U, Kene MV, Anderson ML, Hess EP, Ballard DW, Vinson DR, Reed ME; Kaiser Permanente CREST Network Investigators. Performance of Coronary Risk Scores Among Patients With Chest Pain in the Emergency Department. J Am Coll Cardiol. 2018 Feb 13;71(6):606-616. doi: 10.1016/j.jacc.2017.11.064. PMID: 29420956.
  61. Boyle RSJ, Body R. The Diagnostic Accuracy of the Emergency Department Assessment of Chest Pain (EDACS) Score: A Systematic Review and Meta-analysis. Ann Emerg Med. 2021 Apr;77(4):433-441. doi: 10.1016/j.annemergmed.2020.10.020. Epub 2021 Jan 16. PMID: 33461885.
  62. Stiell IG, Clement CM, Brison RJ, Rowe BH, Borgundvaag B, Aaron SD, Lang E, Calder LA, Perry JJ, Forster AJ, Wells GA. A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events. Acad Emerg Med. 2013 Jan;20(1):17-26. doi: 10.1111/acem.12056. PMID: 23570474.
  63. Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Wells GA. Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT-proBNP. Acad Emerg Med. 2017 Mar;24(3):316-327. doi: 10.1111/acem.13141. PMID: 27976497.
  64. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17. PMID: 19762550.
  65. CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk. MDCalc.org. Accessed at: https://www.mdcalc.com/calc/801/cha2ds2-vasc-score-atrial-fibrillation-stroke-risk#creator-insights on February 3, 2023.
  66. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021 Feb 1;42(5):507. Erratum in: Eur Heart J. 2021 Feb 1;42(5):546-547. Erratum in: Eur Heart J. 2021 Oct 21;42(40):4194. PMID: 32860505.
  67. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019 Jul 9;140(2):e125-e151. doi: 10.1161/CIR.0000000000000665. Epub 2019 Jan 28. Erratum in: Circulation. 2019 Aug 6;140(6):e285. PMID: 30686041.
  68. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010 Nov;138(5):1093-100. doi: 10.1378/chest.10-0134. Epub 2010 Mar 18. PMID: 20299623.
  69. Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011 Jan 11;57(2):173-80. doi: 10.1016/j.jacc.2010.09.024. Epub 2010 Nov 24. PMID: 21111555.
  70. Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis. Clin Cardiol. 2015 Sep;38(9):555-61. doi: 10.1002/clc.22435. PMID: 26418409; PMCID: PMC6490831.
  71. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for uppergastrointestinal haemorrhage. Lancet. 2000 Oct 14; 356(9238): 1318-21.
  72. Stanley AJ, Ashley D, Dalton HR, Mowat C, Gaya, GR, et al. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet. 2009 Jan; 373(9657): 42–47.
  73. Stanley AJ, Laine L, Dalton HR, Ngu JH, Schultz M, Abazi R, Zakko L, Thornton S, Wilkinson K, Khor CJ, Murray IA, Laursen SB; International Gastrointestinal Bleeding Consortium. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017 Jan 4;356:i6432. doi: 10.1136/bmj.i6432. PMID: 28053181; PMCID: PMC5217768.
  74. Oakland K, Jairath V, Uberoi R, Guy R, Ayaru L, Mortensen N, Murphy MF, Collins GS. Derivation and validation of a novel risk score for safe discharge after acute lower gastrointestinal bleeding: a modelling study. Lancet Gastroenterol Hepatol. 2017 Sep;2(9):635-643. doi: 10.1016/S2468-1253(17)30150-4. Epub 2017 Jun 23. PMID: 28651935.
  75. Oakland K, Kothiwale S, Forehand T, Jackson E, Bucknall C, Sey MSL, Singh S, Jairath V, Perlin J. External Validation of the Oakland Score to Assess Safe Hospital Discharge Among Adult Patients With Acute Lower Gastrointestinal Bleeding in the US. JAMA Netw Open. 2020 Jul 1;3(7):e209630. doi: 10.1001/jamanetworkopen.2020.9630. PMID: 32633766; PMCID: PMC7341175.
  76. Alvarado A. A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med. 1986 May;15(5):557-64. doi: 10.1016/s0196-0644(86)80993-3. PMID: 3963537.
  77. Coleman JJ, Carr BW, Rogers T, Field MS, Zarzaur BL, Savage SA, Hammer PM, Brewer BL, Feliciano DV, Rozycki GS. The Alvarado score should be used to reduce emergency department length of stay and radiation exposure in select patients with abdominal pain. J Trauma Acute Care Surg. 2018 Jun;84(6):946-950. doi: 10.1097/TA.0000000000001885. PMID: 29521805.
  78. Pogorelić Z, Rak S, Mrklić I, Jurić I. Prospective validation of Alvarado score and Pediatric Appendicitis Score for the diagnosis of acute appendicitis in children. Pediatr Emerg Care. 2015 Mar;31(3):164-8. doi: 10.1097/PEC.0000000000000375. PMID: 25706925.
  79. Kharbanda AB, Vazquez-Benitez G, Ballard DW, Vinson DR, Chettipally UK, Kene MV, Dehmer SP, Bachur RG, Dayan PS, Kuppermann N, O’Connor PJ, Kharbanda EO. Development and Validation of a Novel Pediatric Appendicitis Risk Calculator (pARC). Pediatrics. 2018 Apr;141(4):e20172699. doi: 10.1542/peds.2017-2699. Epub 2018 Mar 13. PMID: 29535251; PMCID: PMC5869337.
  80. Cotton DM, Vinson DR, Vazquez-Benitez G, Margaret Warton E, Reed ME, Chettipally UK, Kene MV, Lin JS, Mark DG, Sax DR, McLachlan ID, Rauchwerger AS, Simon LE, Kharbanda AB, Kharbanda EO, Ballard DW; Clinical Research on Emergency Services and Treatments (CREST) Network. Validation of the Pediatric Appendicitis Risk Calculator (pARC) in a Community Emergency Department Setting. Ann Emerg Med. 2019 Oct;74(4):471-480. doi: 10.1016/j.annemergmed.2019.04.023. Epub 2019 Jun 19. PMID: 31229394; PMCID: PMC8364751.
  81. Moore CL, Bomann S, Daniels B, Luty S, Molinaro A, Singh D, Gross CP. Derivation and validation of a clinical prediction rule for uncomplicated ureteral stone–the STONE score: retrospective and prospective observational cohort studies. BMJ. 2014 Mar 26;348:g2191. doi: 10.1136/bmj.g2191. PMID: 24671981; PMCID: PMC3966515.
  82. Hernandez N, Song Y, Noble VE, Eisner BH. Predicting ureteral stones in emergency department patients with flank pain: an external validation of the STONE score. World J Urol. 2016 Oct;34(10):1443-6. doi: 10.1007/s00345-016-1760-3. Epub 2016 Jan 16. PMID: 26780732.
  83. Wang RC, Rodriguez RM, Moghadassi M, Noble V, Bailitz J, Mallin M, Corbo J, Kang TL, Chu P, Shiboski S, Smith-Bindman R. External Validation of the STONE Score, a Clinical Prediction Rule for Ureteral Stone: An Observational Multi-institutional Study. Ann Emerg Med. 2016 Apr;67(4):423-432.e2. doi: 10.1016/j.annemergmed.2015.08.019. Epub 2015 Oct 3. PMID: 26440490; PMCID: PMC4808407.
  84. Daniels B, Gross CP, Molinaro A, Singh D, Luty S, Jessey R, Moore CL. STONE PLUS: Evaluation of Emergency Department Patients With Suspected Renal Colic, Using a Clinical Prediction Tool Combined With Point-of-Care Limited Ultrasonography. Ann Emerg Med. 2016 Apr;67(4):439-48. doi: 10.1016/j.annemergmed.2015.10.020. Epub 2015 Dec 31. PMID: 26747219; PMCID: PMC5074842.
  85. Perry JJ, Stiell IG, Sivilotti MA, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA. 2013; 310(12): 1248-1255. doi:10.1001/jama.2013.278018.
  86. Bellolio MF, Hess EP, Gilani W, VanDyck TJ, Ostby SA, et al. External validation of the Ottawa subarachnoid hemorrhage clinical decision rule in patients with acute headache. Am J Emerg Med. 2015 Feb; 33(2): 244-9. doi: 10.1016/j.ajem.2014.11.049. Epub 2014 Dec 3.
  87. Perry JJ, Sharma M, Sivilotti ML, Sutherland J, Worster A, Émond M, Stotts G, Jin AY, Oczkowski WJ, Sahlas DJ, Murray HE, MacKey A, Verreault S, Wells GA, Stiell IG. A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics. Stroke. 2014 Jan;45(1):92-100. doi: 10.1161/STROKEAHA.113.003085. Epub 2013 Nov 21. PMID: 24262323.
  88. Perry JJ, Sivilotti MLA, Émond M, Stiell IG, Stotts G, Lee J, Worster A, Morris J, Cheung KW, Jin AY, Oczkowski WJ, Sahlas DJ, Murray HE, Mackey A, Verreault S, Camden MC, Yip S, Teal P, Gladstone DJ, Boulos MI, Chagnon N, Shouldice E, Atzema C, Slaoui T, Teitlebaum J, Abdulaziz K, Nemnom MJ, Wells GA, Sharma M. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study. BMJ. 2021 Feb 4;372:n49. doi: 10.1136/bmj.n49. Erratum in: BMJ. 2021 Feb 18;372:n453. PMID: 33541890; PMCID: PMC7859838.
  89. Quinn JV, Stiell IG, McDermott DA, Sellers KL, Kohn MA, Wells GA. Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes. Ann Emerg Med. 2004 Feb; 43(2): 224-32.
  90. Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006 May; 47(5): 448-54. Epub 2006 Jan 18. PubMed PMID: 16631985.
  91. Birnbaum A, Esses D, Bijur P, Wollowitz A, Gallagher EJ. Failure to validate the San Francisco Syncope Rule in an independent emergency department population. Ann Emerg Med. 2008 Aug; 52(2): 151-9. Epub 2008 Feb 20. PubMed PMID: 18282636.
  92. Snead GR, Wilbur LG. Can the San Francisco Syncope Rule predict short-term serious outcomes in patients presenting with syncope? Ann Emerg Med. 2013;62: 267-268.
  93. Saccilotto RT, Nickel CH, Bucher HC, Steyerberg EW, Bingisser R, Koller MT. San Francisco Syncope Rule to predict short-term serious outcomes: a systematic review. CMAJ. 2011 Oct 18; 183(15): e1116–e1126. doi: 1503/cmaj.101326
  94. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981; 1(3): 239-46.
  95. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA.2004; 291(13): 1587-1595. doi:10.1001/jama.291.13.1587.
  96. Fine AM, Nizet, V, Mandl KD. Large-scale validation of the Centor and McIsaac Scores to predict group A streptococcal pharyngitis. Arch Intern Med. 2012 Jun 11; 172(11): 847–852. doi: 1001/archinternmed.2012.950.
  97. Pichichero ME. Treatment and prevention of streptococcal tonsillopharyngitis. UpToDate.com. Available online at: http://www.uptodate.com/contents/treatment-and-prevention-of-streptococcal-tonsillopharyngitis?source=machineLearning&search=centor+criteria&selectedTitle=1~2&sectionRank=1&anchor=H9#H3. Accessed Dec. 2, 2015.
  98. Wald ER, Green MD, Schwartz B, Barbadora K. A streptococcal score card revisited. Pediatr Emerg Care. 1998; 14(2): 109.
  99. Ebell MH, Smith MA, Barry HC, et al. The rational clinical examination: does this patient have strep throat? JAMA 2000; 284: 2912– 2918.

Additional Online Resources

  • Emergency Medicine Cases podcast: Clinical Decision Rules and Risk Scales. This hour-long podcast discusses the overall use of CDRs and Risk Scales and how they are developed and used, with a discussion with Dr. Ian Stiell, the “father of clinical decision rules” from Ottawa, Canada. http://emergencymedicinecases.com/episode-56-stiell-sessions-clinical-decision-rules-risk-scales/
  • Agile MD app.  You can download the AgileMD app for free and then download the EM Cases Summaries for free.  Within EM Cases Summaries is a link to the “Ottawa CDRs and Risk Scales.” This includes shortcut to the Ottawa Ankle and Knee Rules, the Canadian C-spine and CT Head Rules, and the Ottawa COPD, Heart Failure, and TIA Risk Scores.
  • EmDOCS.net is a FOAMed initiative with a series of posts on Clinical Decision Rules.
  • There are numerous EM blogs and podcasts that provide education for EM trainees and physicians.  Many are listed here: https://www.emra.org/about-emra/publications/recommended-blogs-and-podcasts/. The podcast EMCrit and EM:RAP in particular have episodes on Clinical Decision Rules.

Reviewed and Edited By

Picture of Arif Alper Cevik, MD, FEMAT, FIFEM

Arif Alper Cevik, MD, FEMAT, FIFEM

Prof Cevik is an Emergency Medicine academician at United Arab Emirates University, interested in international emergency medicine, emergency medicine education, medical education, point of care ultrasound and trauma. He is the founder and director of the International Emergency Medicine Education Project – iem-student.org, vice-chair of the International Federation for Emergency Medicine (IFEM) core curriculum and education committee and board member of the Asian Society for Emergency Medicine and Emirati Board of Emergency Medicine.

Cryptic Shock – Identifying the Unseen (PART 1)

Case Presentation

A 68-year-old man presented to the Emergency Department with complaints of breathing difficulty and fever for three days. The patient is a known diabetic and hypertensive.

After detailed history taking, clinical examination, and radiological workup, the patient was diagnosed with right-sided lobar pneumonia (Community-acquired) and immediately started on intravenous antibiotics. In addition, necessary cultures and blood samples were taken for evaluation.

At the time of presentation, his vitals were HR – 92/min, BP – 130/70mmHg, RR – 30/min, SpO2 – 90% with RA à 96% with 2L O2. He underwent bladder catheterization.

During the 1st hour in the ER, the patient had a very low urine output, which continued for the next few hours. Lactate levels were more than 4mmol/L.

Based on the symptoms, oliguria, and hyperlactatemia, the patient was diagnosed to have sepsis and was initiated on fluid resuscitation. After 2 hours, the patient remained oliguric still, and his BP declined to 120/70mmHg.

After 6 hours, the patient’s BP became 110/60mmHg (MAP – 77). He became anuric and developed altered sensorium. Since he did not meet the criteria of septic shock, he was continued on IV fluids and antibiotics.

After 12 hours, the BP became 80/40mmHg (MAP – 63mmHg) à developed Multiorgan Dysfunction Syndrome. He was then started on vasopressors and mechanical ventilation.

By day 3, the patient further deteriorated and went into cardiac arrest. ROSC was not achieved.

Case Analysis

The treatment initiated was based on protocols like Surviving Sepsis Guidelines and Septic Shock management. So how did the process fail in order to adequately resuscitate this patient? Could something have been done more differently?

The case you read above is a very common scenario. Approximately 30% of the people coming to the ER are hypertensive, and around 10% have diabetes mellitus. They form a huge population, among whom the incidence of any other disease increases their morbidity and early mortality.

Before we delve into the pathology in these patients, let us look at the basic definitions of shock/hypotension.

  • SBP < 90mmHg
  • MAP < 65 mmHg
  • Decrease in SBP > 40mmHg
  • Organ Dysfunction
  • Hyperlactatemia
  • Shock: A state of circulatory insufficiency that creates an imbalance between tissue oxygen supply (delivery) and demand (consumption), resulting in end-organ dysfunction.
  • Septic Shock: Adult patients can be identified using the clinical criteria of hypotension requiring the use of vasopressors to maintain MAP of 65mmHg or greater and having a serum lactate level greater than 2 mmol/L persisting after adequate fluids resuscitation.
  • Cryptic Shock: Presence of hyperlactatemia (or systemic hypoperfusion) in a case of sepsis with normotension.

Based on all the information given above;

  1. what do you think was wrong with our patient?
  2. What kind of shock did he have?
  3. Could we have managed him any other way?
  4. When should we have started inotropes?
  5. Did the fact that he was hypertensive and diabetic have to do with his early deterioration? If so, how?
  6. When did the patient-first develop signs of shock?
  7. What are the different signs and symptoms of shock, and how are they recognized in the ER?

Keep your answers ready… 

Part 2 of Cryptic Shock Series – Vascular Pathology and What is considered ‘Shock’ in Hypertensive patients

Part 3 of Cryptic Shock Series – Individualised BP management

Part 4 of Cryptic Shock Series – Latest Trends

References and Further Reading

  1. Ranzani OT, Monteiro MB, Ferreira EM, Santos SR, Machado FR, Noritomi DT; Grupo de Cuidados Críticos Amil. Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock. Rev Bras Ter Intensiva. 2013 Oct-Dec;25(4):270-8. doi: 10.5935/0103-507X.20130047.
  2. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
  3. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M; Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):775-87. doi: 10.1001/jama.2016.0289.
  4. Education Resources – Sepsis Trust
  5. The Research of Predicting Septic Shock – International Emergency Medicine Education Project (iem-student.org)
  6. Sepsis – International Emergency Medicine Education Project (iem-student.org)
  7. Empiric Antibiotics for Sepsis in the ED Infographics – International Emergency Medicine Education Project (iem-student.org)
  8. Sepsis – An Overview and Update – International Emergency Medicine Education Project (iem-student.org)
[cite]

Immediate Management of Paediatric Traumatic Brain Injury

Traumatic brain injury (TBI) has been noted as a leading cause of death and disability in infants, children, and adolescence (Araki, Yokota and Morita, 2017). In the UK alone, it’s approximated 1.4 million individuals attend the emergency department (ED) with head injury, and of those, 33%-50% are children under the age of 15; on top of this, a fifth of those patients admitted have features suggesting skull fracture or brain damage – that’s no small figure (NICE, 2014)! The particular importance of TBI in the paediatric population is that the treatment and management approach differs to adults; this is largely due to the anatomical and physiological differences in children. Furthermore, neurological evaluation in children proves more complex. All in all, children are complicated, and it is of great importance that we are aware of these differences when a paediatric patient arrives at the ED with TBI presentations.

Why is the paediatric population at risk for TBIs?

To delve slightly deeper into physiology and anatomy, there are several reasons children are at high risk of acquiring serious injury from TBIs. The paediatric brain has higher plasticity and deformity. As such, their less rigid skulls and open sutures allow for greater shock absorbance and response to mechanical stresses (Ghajar and Hariri, 1992). This ‘shaking’ of the brain inside the skull can stretch and tear at blood vessels in the brain parenchyma, resulting in cerebral haemorrhage.

Children also have a larger head-to-body size ratio, making the probability of head involvement in injury consequently higher (in comparison to adults); the head is also relatively heavier in a child, making it more vulnerable (especially in injury caused by sudden acceleration).

Young children have weaker neck muscles on top of having relatively heavier heads. Ligaments in the neck are relied on for craniocervical stability more so than the vertebrae. Hence, not only are TBIs more likely, but craniocervical junction lesions can also result from traumatic injury.

How does TBI in children come about?

The common causes of TBI in the paediatric population varies with age (Araki, Yokota and Morita, 2017). Some of these causes can be seen in the table below, which has been adopted from Araki, Yokota, and Morita (2017).

Table 1 Injury characteristics according to age and development

How can TBI in children present?

  • History: dangerous mechanism of injury (e.g. road traffic accidents or fall from a height greater than 1 meter)
  • Glasgow Coma Scale (GCS) less than 15 (at 2 hours after injury)
  • Visible bleeding, bruise, swelling, laceration
  • Signs of base-of-skull fracture:
    •  ‘Panda’ eyes – haemotympanum
    • Battle’s sign – cerebrospinal fluid leakage from ear or nose
  • Seizure (ask about history of epilepsy)
  • Focal neurological deficit
  • Vomiting
  • Loss of consciousness
  • Amnesia lasting more than 5 minutes
  • Abnormal drowsiness 

Note some children won’t have any of these signs, but if there is any suspicion of possible TBI, it should be investigated further.

Immediate management

There are various causes to paediatric TBI – also subdivided into primary and secondary TBI. Primary TBI includes skull fractures and intracranial injury. Secondary TBI can be caused by diffuse cerebral swelling. Primary and secondary TBI will be managed similarly in initial treatment (i.e. in the ED). The goal of baseline treatment is to:

  1. maintain blood flow to the brain
  2. prevent ischaemia (and possible secondary injury)
  3. maintain homeostasis 

Analgesia, Sedation, Seizure Prophylaxis

A level of anaesthesia needs to be achieved to allow for invasive procedures, such as airway management and intracranial pressure (ICP) control. Normally opioids and benzodiazepines are using in combination for analgesia and sedation in children. Instances where a child presents with a severe TBI (defined as a ‘brain injury resulting in a loss of consciousness of greater than 6 hours and a Glasgow Coma Scale of 3 to 8’), a neuromuscular block is used to improve mechanical ventilation, stop shivering, and reduce metabolic demand.

Anticonvulsants have been used in children, in particular infants, as they have a lower seizure threshold. Risk factors for early onset of seizures in infants under the age of 2 include hypotension, child abuse, and a GCS of ≤ 8; note, all of which may occur as a result of, or preceding, a TBI! For severe paediatric TBI cases, immediate prophylactic administration of anticonvulsants has been recommended.

Maintaining Cerebral Perfusion

The gold standard to measure ICP is an external ventricular drain (EVD); which can be used not only to measure ICP but can also be opened to drain additional CSF to reduce ICP. An intraparenchymal intracranial pressure sensor is an immediate invasive method used to detect early increased ICP in children with TBI. Monitoring of both ICP and cerebral perfusion pressure (CPP) is considered standard practice in TBI management in both paediatric and adult populations, as it is associated with better outcomes.

CPP is the pressure gradient which allows for cerebral blood flow. If this pressure is not maintained, the brain will lose adequate blood flow (Ness-Cochinwala and Dwarakanathan, 2019). Elevated CPP can accelerate oedema and increase chances of secondary intracranial hypertension.

Cerebral Perfusion Pressure (CPP) = Mean Arterial Pressure (MAP) – Intracranial Pressure (ICP)

A CPP of around 40-60 mmHg (40-50mmHg in 0-5 year-olds and 50-60mmHg in 6-17 year-olds) is considered ideal. Achieving an adequate CPP can be done by increasing MAP or reducing ICP (using the above equation). Hence it is necessary to have a good understanding of what good target values for MAP and ICP are.

A good target value for MAP is the upper end of ‘normal’ for the child’s age. Reaching this can be done by using fluids (if fluid deficient) or by use of inotropes. The recommended ICP target is < 20mmHg (normal is between 5-15 mmHg and raised ICP is regarded as values over 20mmHg).

When thinking about ICP, it’s useful to remember a mass in the brain; a mass being possible haemorrhage or any other space-occupying lesion. In TBI, oedema is most prominent at around 24-72 hours post-injury. As a result of increased mass, the initial consequence is a displacement of cerebrospinal fluid (CSF) into the spinal cord. Following this, venous blood in the cranium will also be displaced.

If ICP is further elevated, herniation can result – which is serious and often fatal! Signs of uncal herniation can present as unilateral fixed and dilated pupil. Signs of raised ICP can include pupillary dilatation and series of responses known as the ‘Cushing’s Triad’: irregular, decreased respiration (due to impaired brainstem function), bradycardia, and systolic hypertension (widened pulse pressure). Cushing’s triad results from the response of the body to overcome increased ICP by increasing arterial pressure.

Using the Monroe-Kellie Doctrine as a guide, we can predict how to reduce ICP. One management is head positioning. Head-of-bed should be elevated to 30˚, with the head in mid-line position, to encourage cerebral venous drainage. The EVD can also be used to drain CSF.

Commonly, intravenous mannitol and hypertonic saline are used to manage intracranial hypertension in TBI. Mannitol is traditionally used at a dosage of 20% at 0.25-1.0 g/kg – this is repeatedly administered. The plasma osmolality of the patient needs to be kept a close eye on; it should be ≤ 310 mOsm/L. 3% NaCl can be used to raise sodium levels to 140-150 mEg/L – this is slightly higher than normal sodium levels as a higher blood osmolarity will pull water out of neurons and brain cells osmotically and reduce cerebral oedema (Kochanek et al., 2019). Mannitol works in the same manner, however, use with caution as mannitol, being an osmotic diuretic, can cause blood pressure drops and compromise CPP! In last-resort emergency cases, where ICP need to be immediately reduced, a decompressive craniotomy can be performed.

Intravascular Volume Status

Measuring the patient’s central venous pressure (CVP) is a good indicator of the child’s volume status; 4-10 mmHg have been used as target thresholds. Alternatively, you can also monitor urine output (>1mL/kg/hr), blood urea nitrogen, and serum creatinine. Low volume status should be corrected with a fluid bolus. If the patient’s volume status is normal or high, but they remain hypotensive, vasopressors may improve blood pressure. At all costs, hypotension must be avoided, as if can lead to reduced cerebral perfusion and lead to brain ischaemia; on the other end, hypertension can cause severe cerebral oedema and should also be kept an eye on.

Other considerations​ - There have been reports of pituitary dysfunction in 25% of paediatric TBIs (during the acute phase). Do consider this if the patient had refractory hypotension – keep ACTH deficiency in mind!

Ischaemia

Prevent hypoxia at all costs! Hypoxia goes hand-in-hand with cerebral vasodilation – and as we already know, this increases the pressure in the cranium. Additionally, with hypoxia, there will be ischaemia. A minimum haemoglobin target of 7.0 g/dl is advised in a severe paediatric TBI case.

Other considerations​ - Whilst we are on the blood topic, also take care to correct and control any coagulopathies.

Ventilation

At a Paediatric Glasgow Coma Scale (PGCS) of less than 8, airways must be secured with a tracheal tube and mechanical ventilation commenced. SpO2 should be maintained at greater than 92%.

Of course, hypercapnia (CO2 > 6 kPa) and hypocapnia (CO2 < 4 kPa) are both not ideal, and we should maintain paCO2 at 4.5 – 5.3 kPa. However, some sources have suggested a quick fix to reduce ICP is to acutely hyperventilate the patient (as low CO2 results in cerebral vasoconstriction) – it’s suggested that paCO2 can safely go as low as 2.67 kPa before ischaemia kicks in! Mild hyperventilation is recommended (3.9 – 4.6 kPa)(Araki, Yokota and Morita, 2017).

Decreasing Metabolic Demand of the Brain

Body Temperature

What we want is to prevent hyperthermia, as it increases cerebral metabolic demands. Normothermia (36.5˚C – 37.5˚C) can be maintained by use of cooling blankets or antipyretics. There has been debate on whether therapeutic hypothermia has shown any benefit. Some studies have shown that moderate hypothermia for up to 48 hours, followed by slow rewarming, has prevented rebound intracranial hypertension as well as decreased ICP, however, there have not been any confirmed functional outcomes or decreased mortality rates benefits of this method (Adelson et al., 2013; Hutchinson et al., 2008).

Glycaemic control

Persistent hyperglycaemia (glucose > 10 mmol/L) should be treated. Hypoglycaemia (< 4 mmol/L) is much more dangerous. Persistent hyperglycaemia can be managed by reducing the dextrose concentration in IVF (which is usually administered in the first 48 hours of ICU care), or by starting an insulin drip.

A comment on imaging methods

In the UK, the initial investigation choice for detecting acute brain injuries is a CT head scan. A CT scan should be done within an hour of suspected head injury.
If there are no indications for a CT head scan (i.e. the signs/symptoms listed previously), a CT head scan should be performed within 8 hours of injury (NICE, 2014).

MRI scans are not usually done as the initial investigation, however, they have shown to provide information on the patient’s prognosis.

A final and most important note:

Don’t ever forget Safeguarding in children. Unfortunately, child maltreatment is common and can present anywhere. Have a look at the NICE guidelines below for more on how to identify child maltreatment.

Further reading

References

  • Adelson PD, Wisniewski SR, Beca J, Brown SD, Bell M, Muizelaar JP, Okada P, Beers SR, Balasubramani GK, Hirtz D; Paediatric Traumatic Brain Injury Consortium. Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial. Lancet Neurol. 2013 Jun;12(6):546-53. doi: 10.1016/S1474-4422(13)70077-2.
  • Araki T, Yokota H, Morita A. Pediatric Traumatic Brain Injury: Characteristic Features, Diagnosis, and Management. Neurol Med Chir (Tokyo). 2017;57(2):82-93. doi:10.2176/nmc.ra.2016-0191
  • Finnegan R, Kehoe J, McMahon O, Donoghue V, Crimmins D, Caird J, Murphy J. Primary External Ventricular Drains in the Management of Open Myelomeningocele Repairs in the Neonatal Setting in Ireland. Ir Med J. 2019 May 9;112(5):930.
  • Ghajar J, Hariri RJ. Management of pediatric head injury. Pediatr Clin North Am. 1992;39(5):1093-1125. doi:10.1016/s0031-3955(16)38409-7
  • Hutchison JS, Ward RE, Lacroix J, Hébert PC, Barnes MA, Bohn DJ, Dirks PB, Doucette S, Fergusson D, Gottesman R, Joffe AR, Kirpalani HM, Meyer PG, Morris KP, Moher D, Singh RN, Skippen PW; Hypothermia Pediatric Head Injury Trial Investigators and the Canadian Critical Care Trials Group. Hypothermia therapy after traumatic brain injury in children. N Engl J Med. 2008 Jun 5;358(23):2447-56. doi: 10.1056/NEJMoa0706930.
  • Kochanek PM, Tasker RC, Bell MJ, Adelson PD, Carney N, Vavilala MS, Selden NR, Bratton SL, Grant GA, Kissoon N, Reuter-Rice KE, Wainwright MS. Management of Pediatric Severe Traumatic Brain Injury: 2019 Consensus and Guidelines-Based Algorithm for First and Second Tier Therapies. Pediatr Crit Care Med. 2019 Mar;20(3):269-279. doi: 10.1097/PCC.0000000000001737.
  • National Institute for Health and Care Excellence. Head injury: assessment and early management. 2014. Available at: https://www.nice.org.uk/guidance/cg176
  • Ness-Cochinwala M., Dwarakanathan D. Protecting #1 – Neuroprotective Strategies For Traumatic Brain Injury. Paediatric FOAMed. 2019. 
[cite]

You May Like These Too

Triads in Medicine – Rapid Review for Medical Students

triads in medicine

One of the most convenient ways of learning and remembering the main components of disease and identifying a medical condition on an exam are Triads, and medical students/interns/residents swear by them.

Be it a question during rounds, a multiple-choice exam question to be solved, or even in medical practice, the famous triads help physicians recall important characteristics and clinical features of a disease or treatment in an instant.

Since exam season is here, this could serve as a rapid review to recall the most common medical conditions.

While there are a vast number of triads/pentads available online, I have listed the most important (high-yy) ones that every student would be asked about at least once in the duration of their course.

1) Lethal Triad also known as The Trauma Triad of Death
Hypothermia + Coagulopathy + Metabolic Acidosis

2) Beck’s Triad of Cardiac Tamponade
Muffled heart sounds + Distended neck veins + Hypotension

3) Virchow’s Triad – Venous Thrombosis
Hypercoagulability + stasis + endothelial damage

4) Charcot’s Triad – Ascending Cholangitis
Fever with rigors + Right upper quadrant pain + Jaundice

5) Cushing’s Triad – Raised Intracranial Pressure
Bradycardia + Irregular respiration + Hypertension

6) Triad of Ruptured Abdominal Aortic Aneurysm
Severe Abdominal/Back Pain + Hypotension + Pulsatile Abdominal mass

7) Reactive Arthritis
Can’t See (Conjunctivitis) + Can’t Pee (Urethritis) + Can’t Climb a Tree (Arthritis)

8) Triad of Opioid Overdose
Pinpoint pupils + Respiratory Depression + CNS Depression

9) Hakims Triad – Normal Pressure Hydrocephalus
Gait Disturbance + Dementia + Urinary Incontinence

10) Horner’s Syndrome Triad
Ptosis + Miosis + Anydrosis

11) Mackler’s Triad – Oesophageal Perforation (Boerhaave Syndrome)
Vomiting + Lower Thoracic Pain + Subcutaneous Emphysema

12) Pheochromocytoma
Palpitations + Headache + Perspiration (Diaphoresis)

13) Leriche Syndrome
Buttock claudication + Impotence + Symmetrical Atrophy of bilateral lower extremities

14) Rigler’s Triad – Gallstone ileus
Gallstones + Pneumobilia + Small bowel obstruction

15) Whipple’s Triad – Insulinoma
Hypoglycemic attack + Low glucose + Resolving of the attack on glucose administration

16) Meniere’s Disease
Tinnitus + Vertigo + Hearing loss

17) Wernicke’s Encephalopathy- Thiamine Deficiency
Confusion + Ophthalmoplegia + Ataxia

18) Unhappy Triad – Knee Injury
Injury to Anterior Cruciate Ligament + Medial collateral ligament + Medial or Lateral Meniscus

19) Henoch Schonlein Purpura
Purpura + Abdominal pain + Joint pain

20) Meigs Syndrome
Benign ovarian tumor + pleural effusion + ascites

21) Felty’s Syndrome
Rheumatoid Arthritis + Splenomegaly + Neutropenia

22) Cauda Equina Syndrome
Low back pain + Bowel/Bladder Dysfunction + Saddle Anesthesia

23) Meningitis
Fever + Headache + Neck Stiffness

24) Wolf Parkinson White Syndrome
Delta Waves + Short PR Interval + Wide QRS Complex

25) Neurogenic Shock
Bradycardia + Hypotension + Hypothermia

Further Reading

[cite]

The list of useful scores and rules for ED

useful rules for ed

SAFE-BBOP! – A mnemonic for anaphylaxis management in the emergency department

anaphylaxis

While recently experiencing eight incredible weeks of Emergency Medicine rotations, I was reviewing my approach to anaphylaxis. Coincidentally, there was a real case a few days later, and I found the following mnemonic useful. If you’re having trouble remembering the different components of management for adult cases of anaphylaxis in the emergency department, think of SAFE-BBOP

This is not the exact order in which anaphylaxis should be approached, but it may facilitate memorizing commonly-used treatment modalities while learning and reviewing the general approach. The ABC algorithm should be applied first (see: https://iem-student.org/abc-approach-critically-ill/). Following the diagnosis of anaphylaxis, epinephrine should be administered promptly, as delayed administration has been associated with increased mortality (1-4).

SAFE BBOP

S - Steroids

Prednisone 50mg PO or methylprednisolone 125mg IV. Glucocorticoids are theoretically used to prevent a possible biphasic reaction; however, there is limited evidence for this.

A - Antihistamines (H1 and H2)

Ranitidine 150mg PO/50mg IV, Diphenhydramine 25-50mg PO/IV. Their use is based on studies of urticaria and should only be used as an adjunct therapy.

F - Fluids

Normal saline or Ringer’s lactate 1-2 L IV.

B - Beta-blocked

If a patient is on a beta-blocker and is refractory to the administered epinephrine, consider glucagon 1-5mg slow IV bolus over 5mins, followed by an infusion at 5-15mcg/min, titrated to effect.

B - Bronchodilators

For persistent bronchospasm despite epinephrine, an inhaled bronchodilator can be considered, such as salbutamol 2.5-5mg nebulized or 4-8 puffs by MDI with spacer q20 mins x 3. This is based on studies of acute asthma exacerbation and should only be used as an adjunct therapy.

O - Oxygen

Every patient, who is critically ill, requires supportive oxygen treatment.

P - Positioning

Recumbent position with lower extremity elevation (consider left lateral decubitus position for pregnant patients to prevent inferior vena cava compression).

As for disposition considerations, the SAFE system below was introduced by Lieberman et al. (2007) to recognize the four basic actions to address with patients prior to discharge from the emergency department (5).

  • Seek support
  • Allergen identification and avoidance
  • Follow-up for specialty care
  • Epinephrine for emergencies

For a detailed review of anaphylaxis definitions, signs and symptoms, refer to this great Life in the Fast Lane article: https://litfl.com/anaphylaxis/

References

  1. Prince, B.T., Mikhail, I., & Stukus, D.R. (2018). Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities. J Asthma Allergy, 11, 143-151.
  2. Sheikh, A., Shehata, Y., Brown, S.G., & Simons, F.E. (2009). Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy, 64(2), 204.
  3. Simons, F.E. (2008). Emergency treatment of anaphylaxis. BMJ, 336(7654), 1141.
  4. McLean-Tooke, A.P., Bethune, C.A., Fay, A.C., & Spickett, G.P. (2003). Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ, 327, 1332.
  5. Lieberman, P.,Decker, W., Camargo, C.A. Jr., Oconnor, R., Oppenheimer, J., & Simons, F.E. (2007). SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department. Ann Allergy Asthma Immunol 98(6), 519-23. 
 

Further Reading

[cite]

A 19-year-old female presents with sharp right flank pain and shortness of breath

by Stacey Chamberlain

A 19-year-old female presents with sharp right flank pain and shortness of breath that started suddenly the day prior to arrival. The pain is worse with deep inspiration but not related to exertion and not relieved with ibuprofen. She denies anterior chest pain, cough, and fever. She denies leg pain or swelling and recent travel, immobilization, trauma, or surgery. She has no anterior abdominal pain, no dysuria or hematuria and no personal or family history of gallstones, kidney stones, or blood clots. She’s never had this pain before, has no significant past medical history and her only medication is birth control pills. On exam, her vital signs are within normal range, she has normal cardiac and pulmonary exams, no costovertebral angle tenderness, no chest wall or abdominal tenderness and no leg swelling.

Do you need to do any studies to evaluate this patient for a pulmonary embolism?

Pulmonary Embolism Rule-Out Criteria (PERC)

  • Age ≥ 50
  • Heart rate ≥ 100
  • O2 sat on room air < 95%
  • Prior history of venous thromboembolism
  • Trauma or surgery within 4 weeks
  • Hemoptysis
  • Exogenous estrogen
  • Unilateral leg swelling

The PERC CDR was originally derived and validated in 2004 and with a subsequent multi-study center validation in 2008. In the larger validation study, the rule was only to be applied in those patients with a pre-test probability of < 15%, therefore incorporating clinical gestalt prior to using the rule. PERC is a one-way rule, as mentioned above, which tried to identify patients who are so low-risk for pulmonary embolism (PE) as to not require any testing. It does not imply that testing should be done for patients who do not meet criteria, and it is not meant for risk stratification, as opposed to the Wells’ and Geneva scores.

Case Discussion

In order to apply the PERC CDR to the case study patient, the ED physician pre-supposes a pre-test probability of < 15%. If the ED physician has a higher pre-test probability than that, he/she should not use the PERC CDR. If the ED physician, in this case, did indeed have a pre-test probability of < 15%, the case study patient would fail the rule-out due to her use of oral contraceptives. In that case, the ED physician would need to determine if he/she would do further testing which could include a D-dimer, CT chest with contrast, ventilation/perfusion scan, or lower extremity Doppler studies to evaluate for deep vein thromboses (DVTs). The PERC CDR gives no guidance in this case.

[cite]

A 28-year-old man presents to the ED with left ankle pain

by Stacey Chamberlain

A 28-year-old man presents to the ED with left ankle pain after twisting his ankle playing basketball. He is able to bear weight and notes pain and swelling to the lateral aspect of the ankle (he points to just below the lateral malleolus). He denies weakness, numbness, or tingling and has no other injuries. On exam, he is neurovascularly intact. Edema and tenderness are noted slightly anterior and inferior to the lateral malleolus. There is no point tenderness to the distal posterior malleoli bilaterally.

Should you get an X-ray to rule out fracture?

Ottawa Ankle Rule

Pain in the malleolar zone and any one of the following:

  • Bone tenderness along the distal 6 cm of the posterior edge or tip of the tibia (medial malleolus), OR
  • Bone tenderness along the distal 6 cm of the posterior edge or tip of the fibula (lateral malleolus), OR
  • An inability to bear weight both immediately after the trauma and in the ED for four steps.

Ottawa Foot Rule

Pain in the midfoot zone and any one of the following:

  • Bone tenderness at the base of the fifth metatarsal, OR
  • Bone tenderness at the navicular bone, OR
  • An inability to bear weight both immediately after the trauma and in the ED for four steps.

Case Discussion

In the above case, using either CDR, an X-ray is unnecessary.

[cite]

A 36-year-old woman slipped on ice. CT or Not CT?

by Stacey Chamberlain

A 36-year-old woman slipped on ice and fell and hit her head. She reports loss of consciousness for a minute after the event, witnessed by a bystander. She denies headache. She denies weakness, numbness or tingling in her extremities and no changes in vision or speech. She has not vomited. She remembers the event except for the transient loss of consciousness. She doesn’t use any blood thinners. On physical exam, she has a GCS of 15, no palpable skull fracture and no signs of a basilar skull fracture.

Should you get a CT head for this patient to rule out a clinically significant brain injury?

Canadian CT Head Rule

High-Risk Criteria (rules out the need for neurosurgical intervention)

Medium Risk Criteria (rules out clinically important brain injury)

  • GCS < 15 at two hours post-injury
  • Suspected open or depressed skull fracture
  • Any sign of basilar skull fracture (hemotympanum, Raccoon eyes, Battle’s sign, CSF oto or rhinorrhea)
  • Retrograde amnesia to event  ≥ 30 minutes
  • Dangerous mechanism (pedestrian struck by motor vehicle, ejection from the motor vehicle, fall from > 3 feet or > 5 stairs)

The Canadian CT Head Rule (CCHR) only applies to patients with an initial GCS of 13-15, witnessed loss of consciousness (LOC), amnesia to the head injury event, or confusion. The study was only for patients > 16 years of age. Patients were excluded from the study if they had “minor head injuries” that didn’t even meet these criteria. Patients were also excluded if they had signs or symptoms of moderate or severe head injury including GCS < 13, post-traumatic seizure, focal neurologic deficits, or coagulopathy. Other studies have looked at different CDRs for traumatic brain injury including the New Orleans Criteria (NOC). However, CCHR has been found to have superior sensitivity and specificity.

Case Discussion

By applying this rule to the above case, the patient should be considered for imaging due to the mechanism. A fall from standing for an adult patient would constitute a fall from > 3 feet; therefore, although the patient would not likely be high risk and need neurosurgical intervention, the patient might have a positive finding on CT that in many practice settings would warrant an observation admission.

[cite]

A 24-year-old woman presents with headache

by Stacey Chamberlain

A 24-year-old woman presents with headache that began three hours prior to arrival to the ED. The patient was at rest when the headache began. The headache was not described as “thunderclap,” but it did reach maximum severity within the first 30 minutes. The headache is generalized and rated 10/10. She denies head trauma, weakness, numbness, and tingling in her extremities. She denies visual changes, changes in speech and neck pain. She has not taken anything for the headache. She does not have a family history of cerebral aneurysms or polycystic kidney disease. On physical exam, she has a normal neurologic exam and normal neck flexion.

Should you do a head CT and/or a lumbar puncture to evaluate for a sub-arachnoid hemorrhage in this patient?

Ottawa SAH Rule

Investigate if ≥1 high-risk variables present

  • Age ≥ 40
  • Neck pain or stiffness
  • Witnessed loss of consciousness
  • Onset during exertion
  • Thunderclap headache (instantly peaking pain)
  • Limited neck flexion on exam

A CDR to determine risk for sub-arachnoid hemorrhage (SAH) was derived and has been externally validated in a single study. The CDR’s purpose was to identify those at high risk for SAH and included those with acute non-traumatic headaches that reached maximal intensity within one hour and who had normal neurologic exams. Of note, the rule has many inclusion and exclusion criteria that the ED physician must be familiar with and was only derived for patients 16 years or older. The study authors note that the CDR is to identify patients with SAH; it is not an acute headache rule. In the validation study, of over 5,000 ED visits with acute headache, only 9% of those met inclusion criteria. Also, clinical gestalt again plays a role as the authors suggest not to apply the CDR to those who are ultra-high risk with a pre-test probability for SAH of > 50%.

The Ottawa SAH Rule was 100% sensitive but did not lead to reduction of testing vs. current practice. The authors state that the value of the Ottawa SAH Rule would be to standardize physician practice in order to avoid the relatively high rate of missed sub-arachnoid hemorrhages.

Case Discussion

By applying the Ottawa SAH Rule, this patient is low risk and does not require further investigation for a SAH.

[cite]

Mnemonic for Right Lower Quadrant Pain

Open fracture! Antibiotic choice.

ERic Motorcycle accident

A 20-year-old male presents to your ED with a 5 cm wound after he fell off his motorbike. On physical exam, the wound overlays a fractured left tibia but does not show extensive soft tissue damage nor any signs of periosteal stripping or vascular injury. 

Which antibiotic should you give to this patient?

To learn more about it, read chapters below.

Read "Scores" Chapter
Read "Lower Extremity Injuries" Chapter

Quick Read

Gustilo-Anderson Classification

Gustilo-Anderson classification is used for fractures with open wounds and antibiotic coverage.

Gustilo-Anderson Classification

TypeDefinition
Type IOpen fracture, clean wound, wound <1cm in length
Type IIOpen fracture, wound >1cm in length without extensive soft tissue damage, flaps, avulsions
Type IIIOpen fracture with extensive soft tissue laceration, damage, or loss or an open segmental fracture. This type also includes open fractures caused by farm injuries, fractures requiring vascular repair, or fractures that have been open for 8 hours prior to treatment.
Type III AType III fracture with adequate periosteal coverage of the fractured bone despite extensive soft tissue laceration or damage
Type III BType III fracture with extensive soft tissue loss and periosteal stripping and bone damage. Usually associated with massive contamination. It will often need further soft tissue coverage procedure (i.e. free or rotational flap).
Type III CType III fracture associated with arterial injury requiring repair, irrespective of degree of soft tissue injury

According to the above classification, each class should receive the following antibiotics:

  • Type I: 1st generation cephalosporin
  • Type II: 1st generation Cephalosporin +/- Gentamycin
  • Type III: 1st generation Cephalosporin + Gentamycin +/- Penicillin

To learn more about it, read chapters below.

Read "Scores" Chapter
Read "Lower Extremity Injuries" Chapter